data_2kjp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.367 0.127 . . . . 1.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' LYS . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' ASP . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' ASP . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.42 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.471 ' HG ' ' N ' ' A' ' 7' ' ' SER . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 6' ' ' SER . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' ALA . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' LYS . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.463 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' ASP . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 110.668 -0.123 . . . . 1.0 110.668 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.408 ' HG ' ' HZ2' ' A' ' 45' ' ' LYS . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HZ2' ' HG ' ' A' ' 43' ' ' SER . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 14' ' ' ALA . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo . . . . . 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 46' ' ' LYS . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' SER . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.419 ' H ' HD11 ' A' ' 3' ' ' ILE . 3.9 mp . . . . . 0 N--CA 1.459 -0.025 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.652 HH21 ' HZ2' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ2' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 71' ' ' PHE . 9.2 p-10 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 30' ' ' LYS . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' ASP . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HZ3' ' CB ' ' A' ' 61' ' ' GLU . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.512 ' CD1' ' ND2' ' A' ' 11' ' ' ASN . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.586 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.441 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 22' ' ' ASP . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' VAL . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.664 ' HH ' ' HZ3' ' A' ' 45' ' ' LYS . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HZ3' ' HH ' ' A' ' 41' ' ' TYR . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.9 pt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 7' ' ' SER . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.438 ' N ' ' HG ' ' A' ' 6' ' ' SER . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 30' ' ' LYS . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 28' ' ' ASP . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.432 ' OH ' ' CD2' ' A' ' 41' ' ' TYR . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' LEU . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.409 0.147 . . . . 1.0 110.615 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.408 HD21 ' N ' ' A' ' 11' ' ' ASN . 1.2 m-80 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' A' ' 27' ' ' ALA . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.441 ' SD ' ' NZ ' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 30' ' ' LYS . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 28' ' ' ASP . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.42 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 7.0 p30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . -66.74 -54.83 20.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -92.21 -6.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 122.736 -0.273 . . . . 1.0 110.7 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' LYS . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' ASP . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HZ3' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.97 -10.48 4.26 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 19.7 p-10 -111.2 14.98 21.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.598 0.359 . . . . 1.0 110.483 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -166.99 66.63 0.88 Allowed Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.525 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.15 -17.14 50.34 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.587 1.524 . . . . 1.0 111.831 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.77 -27.05 67.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.671 0.272 . . . . 1.0 110.283 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -128.41 160.15 33.16 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.481 0.657 . . . . 1.0 109.48 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.51 137.88 34.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.862 -1.063 . . . . 1.0 110.605 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.567 ' N ' ' HZ3' ' A' ' 46' ' ' LYS . . . 63.62 142.45 0.02 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.4 tt -64.71 -41.85 93.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.98 22.07 26.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t 55.74 99.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.257 -0.275 . . . . 1.0 110.257 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -141.31 11.26 2.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.364 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.51 102.18 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -63.28 144.17 57.17 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -78.75 8.43 5.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.354 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -60.25 -48.05 83.37 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.567 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -69.82 87.08 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.69 -45.39 90.25 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.138 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -168.13 -49.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.172 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.864 -179.779 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.55 -94.22 0.1 Allowed Glycine 0 N--CA 1.467 0.748 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -66.56 -16.14 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' ASP . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' VAL . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.42 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.34 -54.11 5.95 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.36 -8.95 14.95 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.14 75.84 33.75 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.52 -0.17 10.02 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.414 2.076 . . . . 1.0 111.92 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 19.9 p-10 -89.5 -15.78 32.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 155.58 46.09 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.051 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 80' ' ' ILE . . . -139.19 147.83 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.5 -34.38 0.98 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.573 -0.611 . . . . 1.0 111.573 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 78' ' ' ALA . 37.2 pt -139.26 151.08 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.596 0.358 . . . . 1.0 110.084 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.63 76.34 0.03 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t 55.15 100.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.612 0.244 . . . . 1.0 110.6 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -62.86 95.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.756 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' HIS . 51.3 mt 56.1 -125.82 2.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.571 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 56.1 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.661 0.267 . . . . 1.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 84' ' ' LEU . 72.9 m80 -74.72 65.57 1.36 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 1.0 110.125 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.63 -44.82 95.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.01 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 89' ' ' HIS . 52.3 t-80 -167.48 167.37 13.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.136 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.438 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 97.4 m-70 -61.14 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -162.2 157.75 23.53 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.354 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.063 -0.97 . . . . 1.0 110.529 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.86 -123.89 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt -64.6 -43.81 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.471 ' HG ' ' N ' ' A' ' 7' ' ' SER . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 6' ' ' SER . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' ALA . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.05 -57.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.83 14.33 1.11 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -150.39 64.65 6.76 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.22 -14.74 23.08 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.936 1.757 . . . . 1.0 111.639 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.88 -8.61 59.56 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.06 151.8 51.09 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.271 -0.422 . . . . 1.0 109.937 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.92 141.02 36.54 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.827 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.66 -176.96 47.85 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.8 mt -75.89 124.07 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.56 47.8 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.5 145.3 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -62.32 141.0 58.51 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.57 89.1 6.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -63.93 93.44 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.7 m80 54.18 -175.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.893 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -63.64 -174.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -151.22 147.7 27.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 1.0 110.131 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -60.62 -46.44 90.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 81.6 t60 52.66 78.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.956 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.046 -0.978 . . . . 1.0 111.13 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.39 -149.35 51.14 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -62.27 -8.81 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' LYS . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.73 -63.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -89.52 12.91 15.19 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -140.83 57.25 7.78 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.97 -17.24 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.022 1.814 . . . . 1.0 111.365 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -64.75 -10.23 26.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.579 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -134.06 149.76 51.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.696 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -135.55 144.46 46.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.206 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.02 -130.29 10.1 Favored Glycine 0 N--CA 1.475 1.262 0 N-CA-C 110.095 -1.202 . . . . 1.0 110.095 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 81' ' ' GLY . 1.4 pt -93.05 -83.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 116.98 0.39 . . . . 1.0 110.292 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 83' ' ' SER . . . 66.8 64.44 3.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.126 -0.789 . . . . 1.0 111.126 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.7 m -73.83 19.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.737 0.303 . . . . 1.0 110.695 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 81' ' ' GLY . 38.6 t -61.59 -16.95 52.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.671 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.43 139.85 58.57 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -167.88 157.06 9.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.728 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 88' ' ' HIS . 53.6 t60 -169.06 88.2 0.18 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -61.53 -47.68 84.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 70.2 m80 -65.48 161.87 19.13 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -165.9 139.26 4.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.093 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -65.46 -39.38 91.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.419 -179.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.645 ' H3 ' ' H ' ' A' ' 81' ' ' GLY . 26.9 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.92 -160.74 26.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -61.76 -10.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.463 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' ASP . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.517 ' HZ1' ' CA ' ' A' ' 79' ' ' GLY . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.11 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 23.6 p-10 -66.25 -5.76 11.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.585 0.217 . . . . 1.0 111.585 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -138.14 74.89 41.87 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.41 -5.31 13.4 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.399 2.066 . . . . 1.0 111.4 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.16 -19.72 26.56 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.177 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.34 151.73 46.61 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.97 149.7 45.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' CA ' ' HZ1' ' A' ' 46' ' ' LYS . . . 65.56 130.96 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.574 -1.01 . . . . 1.0 110.574 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.33 -48.17 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.645 ' H ' ' H3 ' ' A' ' 1' ' ' ASN . . . 61.4 154.38 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.9 -72.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.0 p -163.82 163.43 23.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.198 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.17 170.34 2.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.251 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -168.09 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -64.0 122.13 15.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.231 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.21 77.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -162.42 156.44 21.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 81.8 t60 54.49 14.53 0.83 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.05 -44.85 94.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.967 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 61.87 -133.37 46.66 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.75 15.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 122.752 -0.264 . . . . 1.0 110.668 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 2' ' ' GLY . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.408 ' HG ' ' HZ2' ' A' ' 45' ' ' LYS . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HZ2' ' HG ' ' A' ' 43' ' ' SER . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 74' ' ' GLU . 90.6 Cg_exo -45.06 -52.34 6.52 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 15.2 p-10 -58.31 -4.52 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 72' ' ' PRO . 36.7 mt-10 -141.07 77.32 20.69 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.64 -11.88 16.87 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.631 1.554 . . . . 1.0 111.391 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -90.53 -18.27 25.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -134.33 146.57 50.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.76 0.424 . . . . 1.0 109.897 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.09 155.06 46.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.987 0.422 . . . . 1.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.61 -173.77 11.9 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -155.56 149.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.48 -120.94 0.58 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.31 -0.716 . . . . 1.0 111.31 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 131.29 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.99 152.64 45.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 86' ' ' HIS . 9.4 mp -67.7 139.6 56.74 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -76.89 17.99 0.39 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 84' ' ' LEU . 59.6 t-80 -58.43 100.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.797 0.332 . . . . 1.0 110.546 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.31 136.71 55.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.246 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -69.18 141.35 54.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.177 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.78 -40.63 93.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.75 152.12 43.43 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.4 m80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.068 -0.967 . . . . 1.0 110.579 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 61.24 -98.72 0.18 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -72.93 11.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 2' ' ' GLY . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 14' ' ' ALA . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -53.06 -38.95 81.08 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -87.89 19.54 3.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.322 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -168.49 64.95 0.63 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.38 -9.59 24.41 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.881 1.721 . . . . 1.0 111.881 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -79.3 -9.54 59.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.759 0.314 . . . . 1.0 110.44 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -144.11 162.92 35.03 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.21 145.85 39.79 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 159.27 0.42 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.4 mt 56.55 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.692 0.282 . . . . 1.0 110.296 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.15 131.39 33.13 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' LEU . 21.2 t -78.26 132.68 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 t -71.1 14.64 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.758 0.314 . . . . 1.0 110.917 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' VAL . 5.0 tp 60.22 34.6 21.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.028 0.442 . . . . 1.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -167.51 92.93 0.4 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.023 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -167.42 -59.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.022 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -62.21 155.75 23.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.507 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -168.16 -15.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.155 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -61.56 -47.17 86.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.365 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -168.09 160.46 11.89 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.938 0.399 . . . . 1.0 110.412 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.049 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.52 -141.71 47.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.34 0.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 46' ' ' LYS . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' SER . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.54 -59.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.38 12.84 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.909 0.385 . . . . 1.0 111.947 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.11 65.56 13.73 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.61 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.48 -9.66 25.55 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 121.764 1.643 . . . . 1.0 111.407 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -87.88 -0.82 57.47 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.129 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -148.75 152.74 37.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.41 144.75 34.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' GLY . . . 166.77 54.02 0.03 OUTLIER Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.99 78.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . 133.95 17.71 1.02 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.71 146.14 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.871 0.367 . . . . 1.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 t -163.02 137.22 6.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 mt -69.41 139.38 54.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.31 178.36 0.54 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.39 113.3 3.55 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.18 -44.23 92.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.4 t60 52.21 86.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.006 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -168.72 86.8 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -165.98 138.07 3.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.841 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.124 -0.941 . . . . 1.0 110.508 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.81 -133.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm -64.72 -43.97 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 73' ' ' ASP . 72.0 Cg_endo -69.14 -73.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 72' ' ' PRO . 76.6 m-20 -61.6 -7.4 3.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.888 0.329 . . . . 1.0 111.888 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -130.91 72.5 81.82 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.28 -11.38 10.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.331 2.021 . . . . 1.0 112.045 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -92.7 1.23 57.38 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.482 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.44 150.87 45.72 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.45 140.47 37.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.123 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.1 -174.18 49.72 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.73 142.94 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.764 0.316 . . . . 1.0 110.599 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.91 73.89 0.04 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 163.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 122.701 0.4 . . . . 1.0 110.415 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 p 54.68 23.25 4.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.172 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.77 -41.95 99.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.422 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -68.58 155.97 38.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -158.65 22.5 0.22 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.204 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -59.98 -39.0 84.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.379 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.602 ' CG ' ' H ' ' A' ' 89' ' ' HIS . 19.8 t60 56.17 -179.17 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.602 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 93.4 m-70 53.65 80.33 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.807 0.337 . . . . 1.0 110.809 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -64.84 -39.4 93.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.255 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.189 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.76 -142.0 48.2 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.7 mt -65.24 -43.08 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.7 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.77 4.62 6.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -151.27 71.13 8.43 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.83 -3.76 11.24 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.468 2.112 . . . . 1.0 111.186 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -78.3 -19.29 53.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.266 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -135.86 151.29 49.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.075 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.92 150.84 43.67 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.219 0.533 . . . . 1.0 110.747 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.63 -119.05 5.97 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 82' ' ' VAL . 66.5 mt -63.31 -45.64 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 -34.15 1.07 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 80' ' ' ILE . 25.8 t 53.17 84.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.72 0.295 . . . . 1.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -63.17 150.16 43.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.181 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -167.58 45.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.972 0.415 . . . . 1.0 109.933 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.44 3.07 4.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.224 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 55.01 -167.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.629 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.0 m80 54.24 98.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.583 -0.281 . . . . 1.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -59.76 -40.41 88.08 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.581 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.69 146.92 22.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.028 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -66.62 -40.54 88.82 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.06 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.555 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.406 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 25.8 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' H ' ' H3 ' ' A' ' 1' ' ' ASN . . . -62.77 -109.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 ' H ' HD11 ' A' ' 3' ' ' ILE . 3.9 mp -63.63 -43.84 98.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HZ1' ' CA ' ' A' ' 79' ' ' GLY . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.652 HH21 ' HZ2' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ2' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.96 -51.29 10.17 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -77.77 16.29 0.71 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.699 0.285 . . . . 1.0 111.47 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -164.92 70.85 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.303 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 -8.29 18.32 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.151 1.901 . . . . 1.0 111.439 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.23 -21.22 56.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.447 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -135.23 154.05 51.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.15 143.6 40.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.046 0.451 . . . . 1.0 110.278 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' CA ' ' HZ1' ' A' ' 46' ' ' LYS . . . 69.19 155.49 0.97 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.49 177.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.842 0.353 . . . . 1.0 110.52 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.87 55.43 0.07 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.74 92.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -71.59 -18.39 62.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.4 mt -62.95 -40.56 98.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.209 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 54.47 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.452 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.8 m80 53.88 -178.4 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.808 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 1.0 110.171 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -63.59 144.35 57.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.175 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.98 118.46 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 51.65 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.205 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.154 -179.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.87 75.51 0.25 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt 36.78 30.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 71' ' ' PHE . 9.2 p-10 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 30' ' ' LYS . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' ASP . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HZ3' ' CB ' ' A' ' 61' ' ' GLU . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.512 ' CD1' ' ND2' ' A' ' 11' ' ' ASN . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.06 -62.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.98 14.6 1.33 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.402 0.281 . . . . 1.0 111.739 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -145.46 63.81 10.02 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.85 -20.62 29.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.823 1.682 . . . . 1.0 111.645 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -71.59 -34.96 70.35 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.484 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -109.93 145.32 37.09 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.02 35.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.042 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.31 -170.0 13.01 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -77.03 130.58 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.22 -174.13 13.6 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.26 149.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.3 p -169.06 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.45 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -72.45 83.99 1.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 84.51 0.79 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.901 -0.407 . . . . 1.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -155.19 148.63 25.09 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.961 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -67.63 142.89 56.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -63.22 140.47 58.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.22 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.35 150.44 48.28 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.79 -45.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.159 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.122 -0.942 . . . . 1.0 110.929 -179.796 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.435 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 3.6 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . -63.67 -51.27 55.39 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -74.01 -9.67 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.586 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.441 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 22' ' ' ASP . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 20' ' ' VAL . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.664 ' HH ' ' HZ3' ' A' ' 45' ' ' LYS . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HZ3' ' HH ' ' A' ' 41' ' ' TYR . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.52 -13.43 5.55 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -103.66 14.43 31.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.431 0.292 . . . . 1.0 110.42 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -164.93 67.77 1.3 Allowed Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.436 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.32 -17.11 53.58 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.652 1.568 . . . . 1.0 111.81 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.81 -11.8 60.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.209 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -137.83 161.48 36.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 80' ' ' ILE . . . -136.22 132.41 35.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.118 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.44 -3.72 5.77 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' H ' ' C ' ' A' ' 78' ' ' ALA . 75.7 mt -130.4 132.15 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 83' ' ' SER . . . -179.21 68.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.93 19.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.581 0.229 . . . . 1.0 110.547 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 81' ' ' GLY . 96.9 p -72.35 52.72 0.28 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.136 0.493 . . . . 1.0 110.368 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 mt -69.34 152.57 44.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.757 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 55.29 60.17 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 1.0 110.725 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' NE2' ' CE1' ' A' ' 87' ' ' HIS . 22.2 p80 -68.19 -17.66 64.39 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.473 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' NE2' ' A' ' 86' ' ' HIS . 71.4 m80 -63.09 125.46 24.09 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.406 ' O ' ' ND1' ' A' ' 90' ' ' HIS . 59.5 t-80 -169.0 -21.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.418 ' O ' ' N ' ' A' ' 91' ' ' HIS . 70.5 m80 -70.96 -18.07 62.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.396 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 88' ' ' HIS . 74.1 m80 53.43 -87.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 89' ' ' HIS . 71.5 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.46 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.51 -133.18 44.77 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.51 -24.02 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.64 -46.24 0.47 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.15 -18.43 65.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 111.708 0.262 . . . . 1.0 111.708 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -132.67 75.18 73.67 Favored Pre-proline 0 N--CA 1.48 1.043 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.145 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.04 -7.81 16.4 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.265 1.977 . . . . 1.0 111.717 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.19 -10.59 41.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.284 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.605 ' NH1' ' H ' ' A' ' 83' ' ' SER . 41.5 ttm180 -144.27 151.5 39.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.736 0.303 . . . . 1.0 110.249 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -142.08 162.02 36.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.789 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.17 -103.14 1.18 Allowed Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.534 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 pt -65.99 143.91 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 1.0 110.606 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.37 -99.77 0.08 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.82 103.62 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.605 ' H ' ' NH1' ' A' ' 77' ' ' ARG . 93.1 p -68.86 157.84 35.72 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.3 mt 54.58 85.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.969 0.414 . . . . 1.0 110.501 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.14 -29.49 70.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.036 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' CG ' ' N ' ' A' ' 87' ' ' HIS . 59.8 t-80 56.58 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.576 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' N ' ' CG ' ' A' ' 86' ' ' HIS . 61.1 t-80 -167.34 153.24 7.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.299 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.82 65.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.966 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -64.14 -44.89 90.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 1.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -168.26 -40.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.1 -0.953 . . . . 1.0 110.681 -179.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.8 -175.39 17.62 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.9 pt -66.32 -22.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.84 -50.24 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -122.16 -43.02 2.34 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.656 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -62.85 110.46 3.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.443 0.464 . . . . 1.0 110.847 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 77' ' ' ARG . 44.3 Cg_endo -87.3 -49.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.129 1.886 . . . . 1.0 111.672 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 22.1 p-10 -60.71 -6.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.68 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' PRO . 12.1 tpt180 -125.03 130.51 52.45 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.266 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.85 37.7 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.08 143.82 0.05 OUTLIER Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.249 -0.741 . . . . 1.0 111.249 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.01 -46.9 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.39 -170.02 34.45 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 110.354 -1.098 . . . . 1.0 110.354 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.62 148.24 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t 49.45 17.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.661 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.39 101.95 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.93 -52.13 46.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -168.35 152.72 6.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.555 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.98 128.21 35.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -74.12 120.13 19.27 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.158 -0.312 . . . . 1.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -70.36 122.47 19.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.728 0.299 . . . . 1.0 110.284 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -66.01 -40.49 91.14 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.102 -0.332 . . . . 1.0 110.102 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.367 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.569 ' N ' ' HG ' ' A' ' 6' ' ' SER . 47.1 p-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.66 -123.66 31.1 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.394 -0.682 . . . . 1.0 111.394 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.2 9.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.569 ' HG ' ' N ' ' A' ' 1' ' ' ASN . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HG2' ' H ' ' A' ' 73' ' ' ASP . 66.8 Cg_endo -68.31 -74.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 22.1 p-10 -71.39 13.74 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 72' ' ' PRO . 49.9 mm-40 -144.9 65.28 12.08 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.15 -11.28 16.3 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.387 2.058 . . . . 1.0 111.394 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.78 -8.25 59.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -137.87 152.27 48.88 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.14 151.56 47.88 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.982 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.11 175.91 1.2 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -82.45 124.79 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.86 151.37 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.25 -72.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.2 t -167.8 138.87 2.9 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.373 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 mt -63.41 -42.79 98.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.501 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.12 112.24 21.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.994 -0.373 . . . . 1.0 109.994 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -72.7 66.17 0.73 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.064 0.459 . . . . 1.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -154.62 89.87 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.047 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.75 5.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.127 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.4 m80 53.58 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.787 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -65.67 138.05 57.73 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 117.983 -1.008 . . . . 1.0 111.161 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 64.42 -170.24 22.38 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt -63.3 -1.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 2' ' ' GLY . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 7' ' ' SER . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.438 ' N ' ' HG ' ' A' ' 6' ' ' SER . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 30' ' ' LYS . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 28' ' ' ASP . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.432 ' OH ' ' CD2' ' A' ' 41' ' ' TYR . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' LEU . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 -10.04 3.38 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -114.63 2.39 14.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.755 0.422 . . . . 1.0 111.159 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.96 67.45 5.25 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.328 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -17.4 53.92 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.916 1.744 . . . . 1.0 111.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.79 -17.85 64.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.338 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -137.49 158.89 43.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.62 135.93 47.34 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.202 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.98 -156.09 41.42 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.8 mt 57.06 75.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.808 0.337 . . . . 1.0 110.146 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.9 87.22 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 84' ' ' LEU . 9.4 p -59.05 -30.87 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.774 0.321 . . . . 1.0 110.343 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 85' ' ' GLU . 75.8 m 52.91 -90.96 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' O ' ' ND1' ' A' ' 86' ' ' HIS . 62.8 tp 54.66 -82.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.588 0.555 . . . . 1.0 110.287 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 83' ' ' SER . 94.6 mt-10 -60.37 137.5 58.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.96 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 84' ' ' LEU . 21.7 p-80 -166.92 -177.03 3.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 54.86 14.71 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.875 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -61.28 -47.85 84.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.486 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.27 134.03 48.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.081 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -62.61 -47.84 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.473 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.261 179.783 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.28 -135.57 3.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.581 -1.007 . . . . 1.0 110.581 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt -60.94 -7.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 O-C-N 122.844 -0.21 . . . . 1.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.408 HD21 ' N ' ' A' ' 11' ' ' ASN . 1.2 m-80 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.91 -12.98 24.09 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.78 11.23 24.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.409 0.284 . . . . 1.0 110.917 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -162.35 67.11 1.94 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 116.55 -0.296 . . . . 1.0 110.497 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.17 -9.02 22.9 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.883 1.722 . . . . 1.0 111.533 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.86 -9.46 59.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.323 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -147.15 156.83 43.31 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.2 166.23 25.36 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.13 -118.41 12.05 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 pt -64.88 158.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 122.464 -0.433 . . . . 1.0 110.257 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.44 125.88 1.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.62 144.09 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.779 0.323 . . . . 1.0 110.341 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -62.08 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.528 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 mt 55.12 105.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.807 0.337 . . . . 1.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.813 0.34 . . . . 1.0 110.493 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -168.11 131.12 1.54 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.941 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -169.19 129.73 1.1 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -169.73 126.49 0.87 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -168.74 -31.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.45 129.85 41.21 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.009 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.917 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 7.2 p30 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 1' ' ' ASN . . . -71.36 -67.39 1.88 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.56 -13.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.424 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 73' ' ' ASP . 86.5 Cg_endo -71.17 -72.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' H ' ' HG2' ' A' ' 72' ' ' PRO . 25.9 p-10 -71.87 10.05 0.78 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.951 0.352 . . . . 1.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.35 67.01 25.09 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 109.968 -0.382 . . . . 1.0 109.968 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.9 -8.65 16.78 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.231 1.954 . . . . 1.0 111.371 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.49 -23.07 66.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.085 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.508 HH12 ' CB ' ' A' ' 83' ' ' SER . 59.7 ttp180 -145.35 157.04 44.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.9 152.58 47.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.35 140.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.36 146.59 13.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.76 175.7 35.75 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 110.053 -1.219 . . . . 1.0 110.053 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.62 -32.94 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 1.0 110.401 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.508 ' CB ' HH12 ' A' ' 77' ' ' ARG . 39.7 t 54.12 -174.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.568 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.3 mt -69.55 142.42 53.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -34.64 78.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.277 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -158.29 179.72 8.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.102 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -155.28 159.64 40.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -68.92 135.23 50.69 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.47 140.35 58.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.82 -41.98 98.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.148 -0.929 . . . . 1.0 110.423 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 64.7 t30 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . 62.15 -144.25 49.03 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.88 -51.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' A' ' 27' ' ' ALA . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.92 -74.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.2 6.33 1.34 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -140.79 67.25 28.45 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.79 -8.88 16.99 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.433 2.088 . . . . 1.0 111.665 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.17 0.64 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.409 0.284 . . . . 1.0 110.646 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -137.69 146.86 44.3 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -142.16 142.64 32.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.38 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.06 -172.11 37.25 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.9 -36.31 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.44 128.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -165.79 148.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 m -160.36 127.99 4.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.56 137.95 39.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.87 151.58 46.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -163.43 18.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 53.27 93.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.578 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -63.17 140.29 58.86 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.04 -42.22 93.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.855 0.359 . . . . 1.0 110.385 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -163.87 154.33 15.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.257 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.062 179.658 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.17 -42.67 99.73 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.65 -23.17 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.441 ' SD ' ' NZ ' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 30' ' ' LYS . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 28' ' ' ASP . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.98 -61.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -59.46 -11.05 3.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.55 0.204 . . . . 1.0 111.55 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.87 77.27 57.38 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.21 -14.63 8.26 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.682 2.255 . . . . 1.0 111.42 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.62 -25.96 62.37 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.443 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -137.25 154.34 50.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.939 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.5 146.49 42.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.73 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 55.21 91.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.496 -0.642 . . . . 1.0 111.496 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -148.91 142.89 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.858 0.361 . . . . 1.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.74 89.72 1.5 Allowed Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.219 -1.152 . . . . 1.0 110.219 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.77 138.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.3 t -73.16 87.14 1.41 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.87 0.367 . . . . 1.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.74 -36.95 85.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.397 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -55.36 -22.43 19.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -61.12 -49.1 78.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.411 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -84.21 151.26 24.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -64.85 134.75 54.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.125 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -66.11 126.24 28.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -73.96 143.92 45.45 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.015 -0.993 . . . . 1.0 109.922 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.367 0.127 . . . . 1.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' VAL . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HZ2' ' A' ' 54' ' ' LYS . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HZ2' ' HB ' ' A' ' 25' ' ' ILE . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.565 ' H ' HD13 ' A' ' 66' ' ' LEU . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.417 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 21' ' ' GLY . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 20' ' ' VAL . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 5' ' ' ALA . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' HD11 ' A' ' 68' ' ' LEU . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.645 ' O ' HD12 ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 20' ' ' VAL . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 68' ' ' LEU . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 51' ' ' VAL . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 110.668 -0.123 . . . . 1.0 110.668 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' H ' ' HB2' ' A' ' 22' ' ' ASP . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 19' ' ' GLU . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 46' ' ' LYS . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' LEU . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.541 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 20' ' ' VAL . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 38' ' ' LEU . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 65' ' ' THR . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo . . . . . 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 44' ' ' SER . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 42' ' ' ILE . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 68' ' ' LEU . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' A' ' 68' ' ' LEU . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 68' ' ' LEU . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 HG11 ' A' ' 51' ' ' VAL . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.403 HD21 ' CD ' ' A' ' 72' ' ' PRO . 17.0 p-10 -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 46' ' ' LYS . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 51' ' ' VAL . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' CD ' HD21 ' A' ' 11' ' ' ASN . 72.0 Cg_endo . . . . . 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 24' ' ' ILE . 55.7 mt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 52' ' ' THR . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 51' ' ' VAL . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 24' ' ' ILE . 3.9 mp . . . . . 0 N--CA 1.459 -0.025 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 43' ' ' SER . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 42' ' ' ILE . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 52' ' ' THR . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 51' ' ' VAL . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' GLU . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.588 HH21 ' NZ ' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.588 ' NZ ' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' THR . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.472 HD12 ' HZ2' ' A' ' 54' ' ' LYS . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HZ2' HD12 ' A' ' 25' ' ' ILE . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 56' ' ' GLU . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 55' ' ' ILE . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.596 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 56' ' ' GLU . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 55' ' ' ILE . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 65' ' ' THR . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 24' ' ' ILE . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 35' ' ' ALA . 18.9 pt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 11' ' ' ASN . 3.1 p-10 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 3' ' ' ILE . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' CG1' HD21 ' A' ' 68' ' ' LEU . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD21 ' CG1' ' A' ' 51' ' ' VAL . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 40' ' ' ASP . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 39' ' ' ILE . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.575 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.451 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 39' ' ' ILE . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 52' ' ' THR . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 51' ' ' VAL . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.409 0.147 . . . . 1.0 110.615 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 m120 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' VAL . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.456 HD23 ' NZ ' ' A' ' 17' ' ' LYS . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 68' ' ' LEU . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' GLU . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' H ' HG23 ' A' ' 52' ' ' THR . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 68' ' ' LEU . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 68' ' ' LEU . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 52' ' ' THR . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.581 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 46' ' ' LYS . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.571 ' CE ' ' HZ3' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HZ3' ' CE ' ' A' ' 12' ' ' MET . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' ASP . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' ILE . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' ILE . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 66' ' ' LEU . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 7.0 p30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 1' ' ' ASN . . . -66.74 -54.83 20.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -92.21 -6.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 122.736 -0.273 . . . . 1.0 110.7 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' VAL . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HZ2' ' A' ' 54' ' ' LYS . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HZ2' ' HB ' ' A' ' 25' ' ' ILE . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.565 ' H ' HD13 ' A' ' 66' ' ' LEU . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.97 -10.48 4.26 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 19.7 p-10 -111.2 14.98 21.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.598 0.359 . . . . 1.0 110.483 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -166.99 66.63 0.88 Allowed Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.525 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.15 -17.14 50.34 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.587 1.524 . . . . 1.0 111.831 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.77 -27.05 67.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.671 0.272 . . . . 1.0 110.283 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -128.41 160.15 33.16 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.481 0.657 . . . . 1.0 109.48 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.51 137.88 34.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.862 -1.063 . . . . 1.0 110.605 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.579 ' N ' ' HZ2' ' A' ' 46' ' ' LYS . . . 63.62 142.45 0.02 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.4 tt -64.71 -41.85 93.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.98 22.07 26.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t 55.74 99.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.257 -0.275 . . . . 1.0 110.257 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -141.31 11.26 2.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.364 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.51 102.18 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -63.28 144.17 57.17 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -78.75 8.43 5.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.354 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -60.25 -48.05 83.37 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.567 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -69.82 87.08 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.69 -45.39 90.25 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.138 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -168.13 -49.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.172 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.864 -179.779 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 170.55 -94.22 0.1 Allowed Glycine 0 N--CA 1.467 0.748 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -66.56 -16.14 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.417 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.34 -54.11 5.95 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.36 -8.95 14.95 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.14 75.84 33.75 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.52 -0.17 10.02 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.414 2.076 . . . . 1.0 111.92 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 19.9 p-10 -89.5 -15.78 32.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 155.58 46.09 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.051 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 80' ' ' ILE . . . -139.19 147.83 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.5 -34.38 0.98 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.573 -0.611 . . . . 1.0 111.573 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 78' ' ' ALA . 37.2 pt -139.26 151.08 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.596 0.358 . . . . 1.0 110.084 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.63 76.34 0.03 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t 55.15 100.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.612 0.244 . . . . 1.0 110.6 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -62.86 95.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.756 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' HIS . 51.3 mt 56.1 -125.82 2.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.571 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 56.1 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.661 0.267 . . . . 1.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 84' ' ' LEU . 72.9 m80 -74.72 65.57 1.36 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 1.0 110.125 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.63 -44.82 95.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.01 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.601 ' HD1' ' H ' ' A' ' 90' ' ' HIS . 52.3 t-80 -167.48 167.37 13.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.136 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.438 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 97.4 m-70 -61.14 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.601 ' H ' ' HD1' ' A' ' 88' ' ' HIS . 42.8 p-80 -162.2 157.75 23.53 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.354 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.063 -0.97 . . . . 1.0 110.529 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.86 -123.89 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt -64.6 -43.81 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.05 -57.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.83 14.33 1.11 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -150.39 64.65 6.76 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.22 -14.74 23.08 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.936 1.757 . . . . 1.0 111.639 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.88 -8.61 59.56 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.06 151.8 51.09 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.271 -0.422 . . . . 1.0 109.937 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.92 141.02 36.54 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.827 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.66 -176.96 47.85 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.8 mt -75.89 124.07 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.56 47.8 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.5 145.3 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -62.32 141.0 58.51 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -82.57 89.1 6.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -63.93 93.44 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.7 m80 54.18 -175.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.893 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -63.64 -174.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -151.22 147.7 27.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 1.0 110.131 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -60.62 -46.44 90.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 81.6 t60 52.66 78.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.956 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.046 -0.978 . . . . 1.0 111.13 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.39 -149.35 51.14 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -62.27 -8.81 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 21' ' ' GLY . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 20' ' ' VAL . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 5' ' ' ALA . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' HD11 ' A' ' 68' ' ' LEU . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.645 ' O ' HD12 ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.73 -63.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -89.52 12.91 15.19 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -140.83 57.25 7.78 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.97 -17.24 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.022 1.814 . . . . 1.0 111.365 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -64.75 -10.23 26.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.579 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -134.06 149.76 51.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.696 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -135.55 144.46 46.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.206 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.02 -130.29 10.1 Favored Glycine 0 N--CA 1.475 1.262 0 N-CA-C 110.095 -1.202 . . . . 1.0 110.095 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 81' ' ' GLY . 1.4 pt -93.05 -83.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 116.98 0.39 . . . . 1.0 110.292 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 83' ' ' SER . . . 66.8 64.44 3.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.126 -0.789 . . . . 1.0 111.126 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.7 m -73.83 19.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.737 0.303 . . . . 1.0 110.695 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 81' ' ' GLY . 38.6 t -61.59 -16.95 52.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.671 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.43 139.85 58.57 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -167.88 157.06 9.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.728 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -169.06 88.2 0.18 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -61.53 -47.68 84.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -65.48 161.87 19.13 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -165.9 139.26 4.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.093 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -65.46 -39.38 91.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.419 -179.768 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.556 ' H1 ' ' H ' ' A' ' 81' ' ' GLY . 26.9 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.92 -160.74 26.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -61.76 -10.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 20' ' ' VAL . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' CG ' ' HE2' ' A' ' 86' ' ' HIS . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 68' ' ' LEU . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 51' ' ' VAL . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.11 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 23.6 p-10 -66.25 -5.76 11.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.585 0.217 . . . . 1.0 111.585 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -138.14 74.89 41.87 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.41 -5.31 13.4 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.399 2.066 . . . . 1.0 111.4 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.16 -19.72 26.56 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.177 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.34 151.73 46.61 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.97 149.7 45.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.56 130.96 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.574 -1.01 . . . . 1.0 110.574 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.33 -48.17 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' H1 ' ' A' ' 1' ' ' ASN . . . 61.4 154.38 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.9 -72.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.0 p -163.82 163.43 23.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.198 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.17 170.34 2.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.251 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -168.09 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.419 ' HE2' ' CG ' ' A' ' 40' ' ' ASP . 97.1 m-70 -64.0 122.13 15.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.231 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.21 77.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -162.42 156.44 21.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 81.8 t60 54.49 14.53 0.83 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.05 -44.85 94.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.967 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 61.87 -133.37 46.66 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.75 15.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 122.752 -0.264 . . . . 1.0 110.668 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 2' ' ' GLY . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' H ' ' HB2' ' A' ' 22' ' ' ASP . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 19' ' ' GLU . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 46' ' ' LYS . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' LEU . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.541 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.06 -52.34 6.52 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 15.2 p-10 -58.31 -4.52 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.07 77.32 20.69 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.64 -11.88 16.87 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.631 1.554 . . . . 1.0 111.391 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -90.53 -18.27 25.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -134.33 146.57 50.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.76 0.424 . . . . 1.0 109.897 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.09 155.06 46.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.987 0.422 . . . . 1.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.61 -173.77 11.9 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -155.56 149.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.48 -120.94 0.58 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.31 -0.716 . . . . 1.0 111.31 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 131.29 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.99 152.64 45.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.4 mp -67.7 139.6 56.74 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -76.89 17.99 0.39 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 84' ' ' LEU . 59.6 t-80 -58.43 100.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.797 0.332 . . . . 1.0 110.546 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.31 136.71 55.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.246 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -69.18 141.35 54.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.177 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.78 -40.63 93.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.75 152.12 43.43 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.4 m80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.068 -0.967 . . . . 1.0 110.579 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 61.24 -98.72 0.18 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -72.93 11.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 2' ' ' GLY . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 20' ' ' VAL . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 38' ' ' LEU . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 65' ' ' THR . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -53.06 -38.95 81.08 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -87.89 19.54 3.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.322 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -168.49 64.95 0.63 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.38 -9.59 24.41 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.881 1.721 . . . . 1.0 111.881 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -79.3 -9.54 59.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.759 0.314 . . . . 1.0 110.44 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -144.11 162.92 35.03 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.21 145.85 39.79 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 159.27 0.42 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.4 mt 56.55 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.692 0.282 . . . . 1.0 110.296 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.15 131.39 33.13 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 84' ' ' LEU . 21.2 t -78.26 132.68 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 t -71.1 14.64 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.758 0.314 . . . . 1.0 110.917 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 82' ' ' VAL . 5.0 tp 60.22 34.6 21.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.028 0.442 . . . . 1.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -167.51 92.93 0.4 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.023 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -167.42 -59.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.022 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -62.21 155.75 23.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.507 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 89' ' ' HIS . 18.0 p-80 -168.16 -15.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.155 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 88' ' ' HIS . 58.9 t-80 -61.56 -47.17 86.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -168.09 160.46 11.89 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.938 0.399 . . . . 1.0 110.412 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.049 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.52 -141.71 47.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.34 0.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 44' ' ' SER . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 42' ' ' ILE . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 68' ' ' LEU . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' A' ' 68' ' ' LEU . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 68' ' ' LEU . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 HG11 ' A' ' 51' ' ' VAL . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.409 ' N ' HD11 ' A' ' 80' ' ' ILE . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.54 -59.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.38 12.84 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.909 0.385 . . . . 1.0 111.947 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.11 65.56 13.73 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.61 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.48 -9.66 25.55 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 121.764 1.643 . . . . 1.0 111.407 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -87.88 -0.82 57.47 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.129 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -148.75 152.74 37.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.41 144.75 34.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' GLY . . . 166.77 54.02 0.03 OUTLIER Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 71' ' ' PHE . 33.3 mm -62.99 78.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . 133.95 17.71 1.02 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.71 146.14 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.871 0.367 . . . . 1.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 t -163.02 137.22 6.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 mt -69.41 139.38 54.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.31 178.36 0.54 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.39 113.3 3.55 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.18 -44.23 92.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.4 t60 52.21 86.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.006 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -168.72 86.8 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -165.98 138.07 3.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.841 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.124 -0.941 . . . . 1.0 110.508 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.81 -133.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm -64.72 -43.97 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.403 HD21 ' CD ' ' A' ' 72' ' ' PRO . 17.0 p-10 -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 46' ' ' LYS . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 51' ' ' VAL . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' CD ' HD21 ' A' ' 11' ' ' ASN . 72.0 Cg_endo -69.14 -73.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.6 -7.4 3.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.888 0.329 . . . . 1.0 111.888 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -130.91 72.5 81.82 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.28 -11.38 10.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.331 2.021 . . . . 1.0 112.045 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -92.7 1.23 57.38 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.482 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.44 150.87 45.72 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.45 140.47 37.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.123 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.1 -174.18 49.72 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.73 142.94 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.764 0.316 . . . . 1.0 110.599 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.91 73.89 0.04 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 163.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 122.701 0.4 . . . . 1.0 110.415 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 p 54.68 23.25 4.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.172 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.77 -41.95 99.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.422 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -68.58 155.97 38.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -158.65 22.5 0.22 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.204 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -59.98 -39.0 84.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.379 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CG ' ' H ' ' A' ' 89' ' ' HIS . 19.8 t60 56.17 -179.17 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 93.4 m-70 53.65 80.33 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.807 0.337 . . . . 1.0 110.809 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -64.84 -39.4 93.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.255 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.189 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.76 -142.0 48.2 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 24' ' ' ILE . 55.7 mt -65.24 -43.08 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 52' ' ' THR . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 51' ' ' VAL . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.7 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.77 4.62 6.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -151.27 71.13 8.43 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.83 -3.76 11.24 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.468 2.112 . . . . 1.0 111.186 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -78.3 -19.29 53.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.266 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -135.86 151.29 49.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.075 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.92 150.84 43.67 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.219 0.533 . . . . 1.0 110.747 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.63 -119.05 5.97 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 82' ' ' VAL . 66.5 mt -63.31 -45.64 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 -34.15 1.07 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 80' ' ' ILE . 25.8 t 53.17 84.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.72 0.295 . . . . 1.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -63.17 150.16 43.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.181 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -167.58 45.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.972 0.415 . . . . 1.0 109.933 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.44 3.07 4.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.224 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 55.01 -167.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.629 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.0 m80 54.24 98.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.583 -0.281 . . . . 1.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -59.76 -40.41 88.08 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.581 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.69 146.92 22.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.028 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -66.62 -40.54 88.82 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.06 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.555 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.77 -109.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.521 HD12 ' H ' ' A' ' 3' ' ' ILE . 3.9 mp -63.63 -43.84 98.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 43' ' ' SER . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 42' ' ' ILE . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 52' ' ' THR . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 51' ' ' VAL . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' GLU . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.588 HH21 ' NZ ' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.588 ' NZ ' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' THR . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.96 -51.29 10.17 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -77.77 16.29 0.71 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.699 0.285 . . . . 1.0 111.47 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -164.92 70.85 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.303 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 -8.29 18.32 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.151 1.901 . . . . 1.0 111.439 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.23 -21.22 56.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.447 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -135.23 154.05 51.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.15 143.6 40.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.046 0.451 . . . . 1.0 110.278 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.19 155.49 0.97 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.49 177.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.842 0.353 . . . . 1.0 110.52 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.87 55.43 0.07 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.74 92.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -71.59 -18.39 62.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.4 mt -62.95 -40.56 98.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.209 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 54.47 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.452 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.8 m80 53.88 -178.4 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.808 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 1.0 110.171 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -63.59 144.35 57.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.175 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.98 118.46 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 51.65 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.205 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.154 -179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.87 75.51 0.25 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt 36.78 30.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.472 HD12 ' HZ2' ' A' ' 54' ' ' LYS . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HZ2' HD12 ' A' ' 25' ' ' ILE . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 56' ' ' GLU . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 55' ' ' ILE . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.06 -62.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.98 14.6 1.33 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.402 0.281 . . . . 1.0 111.739 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -145.46 63.81 10.02 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.85 -20.62 29.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.823 1.682 . . . . 1.0 111.645 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -71.59 -34.96 70.35 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.484 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -109.93 145.32 37.09 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.02 35.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.042 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.31 -170.0 13.01 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -77.03 130.58 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.22 -174.13 13.6 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.26 149.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.443 ' H ' ' H ' ' A' ' 84' ' ' LEU . 96.3 p -169.06 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.45 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.443 ' H ' ' H ' ' A' ' 83' ' ' SER . 37.2 tp -72.45 83.99 1.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 84.51 0.79 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.901 -0.407 . . . . 1.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -155.19 148.63 25.09 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.961 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -67.63 142.89 56.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -63.22 140.47 58.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.22 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.35 150.44 48.28 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.79 -45.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.159 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.122 -0.942 . . . . 1.0 110.929 -179.796 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.403 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 3.6 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . -63.67 -51.27 55.39 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -74.01 -9.67 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.596 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 56' ' ' GLU . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 55' ' ' ILE . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 65' ' ' THR . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.52 -13.43 5.55 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -103.66 14.43 31.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.431 0.292 . . . . 1.0 110.42 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -164.93 67.77 1.3 Allowed Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.436 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.32 -17.11 53.58 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.652 1.568 . . . . 1.0 111.81 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.81 -11.8 60.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.209 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -137.83 161.48 36.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.22 132.41 35.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.118 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.44 -3.72 5.77 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.4 132.15 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 83' ' ' SER . . . -179.21 68.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.93 19.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.581 0.229 . . . . 1.0 110.547 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 81' ' ' GLY . 96.9 p -72.35 52.72 0.28 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.136 0.493 . . . . 1.0 110.368 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 mt -69.34 152.57 44.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.757 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 55.29 60.17 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 1.0 110.725 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CE1' ' NE2' ' A' ' 87' ' ' HIS . 43.9 p-80 -68.19 -17.66 64.39 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.473 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.443 ' NE2' ' CE1' ' A' ' 86' ' ' HIS . 90.1 m-70 -63.09 125.46 24.09 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.406 ' O ' ' ND1' ' A' ' 90' ' ' HIS . 59.5 t-80 -169.0 -21.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.418 ' O ' ' N ' ' A' ' 91' ' ' HIS . 70.5 m80 -70.96 -18.07 62.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.396 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 88' ' ' HIS . 74.1 m80 53.43 -87.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 89' ' ' HIS . 71.5 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.46 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.51 -133.18 44.77 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.51 -24.02 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 24' ' ' ILE . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.64 -46.24 0.47 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.15 -18.43 65.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 111.708 0.262 . . . . 1.0 111.708 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -132.67 75.18 73.67 Favored Pre-proline 0 N--CA 1.48 1.043 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.145 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.04 -7.81 16.4 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.265 1.977 . . . . 1.0 111.717 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.19 -10.59 41.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.284 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.615 ' NH1' ' H ' ' A' ' 83' ' ' SER . 41.5 ttm180 -144.27 151.5 39.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.736 0.303 . . . . 1.0 110.249 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -142.08 162.02 36.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.789 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.17 -103.14 1.18 Allowed Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.534 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 pt -65.99 143.91 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 1.0 110.606 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.37 -99.77 0.08 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.82 103.62 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.615 ' H ' ' NH1' ' A' ' 77' ' ' ARG . 93.1 p -68.86 157.84 35.72 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.3 mt 54.58 85.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.969 0.414 . . . . 1.0 110.501 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 28.4 mp0 -64.14 -29.49 70.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.036 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' CG ' ' N ' ' A' ' 87' ' ' HIS . 59.8 t-80 56.58 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.576 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' N ' ' CG ' ' A' ' 86' ' ' HIS . 61.1 t-80 -167.34 153.24 7.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.299 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.82 65.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.966 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -64.14 -44.89 90.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 1.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -168.26 -40.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.1 -0.953 . . . . 1.0 110.681 -179.554 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.552 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 65.8 -175.39 17.62 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 35' ' ' ALA . 18.9 pt -66.32 -22.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 11' ' ' ASN . 3.1 p-10 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 3' ' ' ILE . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' CG1' HD21 ' A' ' 68' ' ' LEU . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD21 ' CG1' ' A' ' 51' ' ' VAL . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.84 -50.24 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -122.16 -43.02 2.34 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.656 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -62.85 110.46 3.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.443 0.464 . . . . 1.0 110.847 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -87.3 -49.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.129 1.886 . . . . 1.0 111.672 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 22.1 p-10 -60.71 -6.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.68 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -125.03 130.51 52.45 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.266 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.85 37.7 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.08 143.82 0.05 OUTLIER Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.249 -0.741 . . . . 1.0 111.249 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.01 -46.9 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.39 -170.02 34.45 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 110.354 -1.098 . . . . 1.0 110.354 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.62 148.24 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t 49.45 17.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.661 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.39 101.95 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.93 -52.13 46.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -168.35 152.72 6.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.555 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.98 128.21 35.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -74.12 120.13 19.27 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.158 -0.312 . . . . 1.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.479 ' CD2' ' H ' ' A' ' 89' ' ' HIS . 10.6 p80 -70.36 122.47 19.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.728 0.299 . . . . 1.0 110.284 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -66.01 -40.49 91.14 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.102 -0.332 . . . . 1.0 110.102 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.367 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.66 -123.66 31.1 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.394 -0.682 . . . . 1.0 111.394 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -97.2 9.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 40' ' ' ASP . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 39' ' ' ILE . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -68.31 -74.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 22.1 p-10 -71.39 13.74 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -144.9 65.28 12.08 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.15 -11.28 16.3 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.387 2.058 . . . . 1.0 111.394 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.78 -8.25 59.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -137.87 152.27 48.88 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.14 151.56 47.88 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.982 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.11 175.91 1.2 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -82.45 124.79 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.86 151.37 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.25 -72.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.2 t -167.8 138.87 2.9 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.373 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 mt -63.41 -42.79 98.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.501 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.12 112.24 21.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.994 -0.373 . . . . 1.0 109.994 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -72.7 66.17 0.73 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.064 0.459 . . . . 1.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -154.62 89.87 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.047 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.75 5.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.127 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.4 m80 53.58 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.787 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -65.67 138.05 57.73 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 117.983 -1.008 . . . . 1.0 111.161 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 64.42 -170.24 22.38 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt -63.3 -1.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' GLY . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.451 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 39' ' ' ILE . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 52' ' ' THR . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 51' ' ' VAL . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 -10.04 3.38 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -114.63 2.39 14.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.755 0.422 . . . . 1.0 111.159 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.96 67.45 5.25 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.328 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -17.4 53.92 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.916 1.744 . . . . 1.0 111.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.79 -17.85 64.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.338 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -137.49 158.89 43.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.62 135.93 47.34 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.202 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.98 -156.09 41.42 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.8 mt 57.06 75.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.808 0.337 . . . . 1.0 110.146 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.9 87.22 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 84' ' ' LEU . 9.4 p -59.05 -30.87 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.774 0.321 . . . . 1.0 110.343 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 85' ' ' GLU . 75.8 m 52.91 -90.96 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' O ' ' ND1' ' A' ' 86' ' ' HIS . 62.8 tp 54.66 -82.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.588 0.555 . . . . 1.0 110.287 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 83' ' ' SER . 94.6 mt-10 -60.37 137.5 58.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.96 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 84' ' ' LEU . 21.7 p-80 -166.92 -177.03 3.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 54.86 14.71 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.875 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -61.28 -47.85 84.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.486 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.27 134.03 48.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.081 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -62.61 -47.84 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.473 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.261 179.783 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.28 -135.57 3.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.581 -1.007 . . . . 1.0 110.581 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt -60.94 -7.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 O-C-N 122.844 -0.21 . . . . 1.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 m120 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' VAL . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.456 HD23 ' NZ ' ' A' ' 17' ' ' LYS . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.91 -12.98 24.09 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.78 11.23 24.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.409 0.284 . . . . 1.0 110.917 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -162.35 67.11 1.94 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 116.55 -0.296 . . . . 1.0 110.497 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.17 -9.02 22.9 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.883 1.722 . . . . 1.0 111.533 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.86 -9.46 59.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.323 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -147.15 156.83 43.31 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.2 166.23 25.36 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.13 -118.41 12.05 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 pt -64.88 158.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 122.464 -0.433 . . . . 1.0 110.257 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.44 125.88 1.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.62 144.09 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.779 0.323 . . . . 1.0 110.341 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -62.08 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.528 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 mt 55.12 105.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.807 0.337 . . . . 1.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.813 0.34 . . . . 1.0 110.493 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -168.11 131.12 1.54 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.941 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -169.19 129.73 1.1 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -169.73 126.49 0.87 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -168.74 -31.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.45 129.85 41.21 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.009 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.917 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 7.2 p30 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.539 ' O ' HD11 ' A' ' 24' ' ' ILE . . . -71.36 -67.39 1.88 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.56 -13.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 68' ' ' LEU . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' GLU . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' ASP . 86.5 Cg_endo -71.17 -72.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 72' ' ' PRO . 25.9 p-10 -71.87 10.05 0.78 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.951 0.352 . . . . 1.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.35 67.01 25.09 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 109.968 -0.382 . . . . 1.0 109.968 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.9 -8.65 16.78 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.231 1.954 . . . . 1.0 111.371 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.49 -23.07 66.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.085 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.523 HH12 ' CB ' ' A' ' 83' ' ' SER . 59.7 ttp180 -145.35 157.04 44.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.9 152.58 47.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.35 140.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.36 146.59 13.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.76 175.7 35.75 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 110.053 -1.219 . . . . 1.0 110.053 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.62 -32.94 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 1.0 110.401 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' HH12 ' A' ' 77' ' ' ARG . 39.7 t 54.12 -174.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.568 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.3 mt -69.55 142.42 53.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -34.64 78.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.277 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -158.29 179.72 8.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.102 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -155.28 159.64 40.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -68.92 135.23 50.69 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.47 140.35 58.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.82 -41.98 98.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.148 -0.929 . . . . 1.0 110.423 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 64.7 t30 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . 62.15 -144.25 49.03 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.88 -51.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' H ' HG23 ' A' ' 52' ' ' THR . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 68' ' ' LEU . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 68' ' ' LEU . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 52' ' ' THR . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.581 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 46' ' ' LYS . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.92 -74.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.2 6.33 1.34 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -140.79 67.25 28.45 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.79 -8.88 16.99 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.433 2.088 . . . . 1.0 111.665 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.17 0.64 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.409 0.284 . . . . 1.0 110.646 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -137.69 146.86 44.3 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 44' ' ' SER . . . -142.16 142.64 32.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.38 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.06 -172.11 37.25 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.9 -36.31 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.44 128.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -165.79 148.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 m -160.36 127.99 4.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 84' ' ' LEU . 4.0 mm? -76.56 137.95 39.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.87 151.58 46.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -163.43 18.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 53.27 93.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.578 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -63.17 140.29 58.86 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.04 -42.22 93.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.855 0.359 . . . . 1.0 110.385 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -163.87 154.33 15.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.257 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.062 179.658 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 24' ' ' ILE . . . -62.17 -42.67 99.73 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.65 -23.17 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.571 ' CE ' ' HZ3' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HZ3' ' CE ' ' A' ' 12' ' ' MET . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' ASP . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' ILE . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' ILE . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 66' ' ' LEU . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.98 -61.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -59.46 -11.05 3.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.55 0.204 . . . . 1.0 111.55 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.87 77.27 57.38 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.21 -14.63 8.26 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.682 2.255 . . . . 1.0 111.42 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.62 -25.96 62.37 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.443 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -137.25 154.34 50.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.939 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.5 146.49 42.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.73 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 55.21 91.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.496 -0.642 . . . . 1.0 111.496 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -148.91 142.89 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.858 0.361 . . . . 1.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.74 89.72 1.5 Allowed Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.219 -1.152 . . . . 1.0 110.219 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.77 138.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.3 t -73.16 87.14 1.41 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.87 0.367 . . . . 1.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.74 -36.95 85.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.397 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -55.36 -22.43 19.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -61.12 -49.1 78.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.411 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -84.21 151.26 24.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -64.85 134.75 54.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.125 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -66.11 126.24 28.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -73.96 143.92 45.45 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.015 -0.993 . . . . 1.0 109.922 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.367 0.127 . . . . 1.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' VAL . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HZ2' ' A' ' 54' ' ' LYS . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HZ2' ' HB ' ' A' ' 25' ' ' ILE . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.565 ' H ' HD13 ' A' ' 66' ' ' LEU . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.417 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 21' ' ' GLY . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 20' ' ' VAL . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 5' ' ' ALA . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' HD11 ' A' ' 68' ' ' LEU . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.645 ' O ' HD12 ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 20' ' ' VAL . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 68' ' ' LEU . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 51' ' ' VAL . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 110.668 -0.123 . . . . 1.0 110.668 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' H ' ' HB2' ' A' ' 22' ' ' ASP . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 19' ' ' GLU . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 46' ' ' LYS . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' LEU . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.541 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 20' ' ' VAL . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 65' ' ' THR . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo . . . . . 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 44' ' ' SER . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 42' ' ' ILE . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 68' ' ' LEU . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' A' ' 68' ' ' LEU . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 68' ' ' LEU . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 HG11 ' A' ' 51' ' ' VAL . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 46' ' ' LYS . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 51' ' ' VAL . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 24' ' ' ILE . 55.7 mt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 52' ' ' THR . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 51' ' ' VAL . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 24' ' ' ILE . 3.9 mp . . . . . 0 N--CA 1.459 -0.025 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 43' ' ' SER . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 42' ' ' ILE . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 52' ' ' THR . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 51' ' ' VAL . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' GLU . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.588 HH21 ' NZ ' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.588 ' NZ ' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' THR . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 71' ' ' PHE . 9.2 p-10 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.472 HD12 ' HZ2' ' A' ' 54' ' ' LYS . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HZ2' HD12 ' A' ' 25' ' ' ILE . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 56' ' ' GLU . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 55' ' ' ILE . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.512 ' CD1' ' ND2' ' A' ' 11' ' ' ASN . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.596 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 56' ' ' GLU . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 55' ' ' ILE . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 65' ' ' THR . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 24' ' ' ILE . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 35' ' ' ALA . 18.9 pt . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 3' ' ' ILE . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' CG1' HD21 ' A' ' 68' ' ' LEU . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD21 ' CG1' ' A' ' 51' ' ' VAL . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo . . . . . 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 40' ' ' ASP . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 39' ' ' ILE . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.575 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.451 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 39' ' ' ILE . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 52' ' ' THR . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 51' ' ' VAL . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.409 0.147 . . . . 1.0 110.615 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 11' ' ' ASN . 1.2 m-80 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' VAL . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.456 HD23 ' NZ ' ' A' ' 17' ' ' LYS . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 68' ' ' LEU . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' GLU . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' H ' HG23 ' A' ' 52' ' ' THR . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 68' ' ' LEU . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 68' ' ' LEU . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 52' ' ' THR . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.581 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 46' ' ' LYS . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.571 ' CE ' ' HZ3' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HZ3' ' CE ' ' A' ' 12' ' ' MET . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' ASP . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' ILE . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' ILE . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 66' ' ' LEU . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 7.0 p30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 1' ' ' ASN . . . -66.74 -54.83 20.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -92.21 -6.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 122.736 -0.273 . . . . 1.0 110.7 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -149.71 98.57 2.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.442 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.3 171.66 11.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.025 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.9 p -164.85 -33.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -170.97 127.35 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.821 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.39 138.75 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.967 -0.383 . . . . 1.0 109.967 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.58 141.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-O 120.873 0.368 . . . . 1.0 110.149 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.48 -126.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 61.26 19.64 10.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.471 0.308 . . . . 1.0 111.045 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -129.24 167.89 18.2 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' LYS . 72.5 Cg_exo -55.71 -33.82 88.77 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 121.635 1.556 . . . . 1.0 112.567 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.09 12.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.111 -0.495 . . . . 1.0 112.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.3 tttp -80.23 110.27 15.5 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 111.712 0.264 . . . . 1.0 111.712 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.77 -10.39 60.04 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -127.13 111.69 14.29 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -132.5 149.52 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' VAL . 93.9 mt-10 -144.0 106.72 4.45 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.0 m -160.86 60.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.416 0.627 . . . . 1.0 109.599 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.03 -17.76 47.71 Favored Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.485 -1.046 . . . . 1.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -59.95 168.68 1.73 Allowed 'General case' 0 C--N 1.339 0.128 0 O-C-N 122.584 -0.362 . . . . 1.0 110.08 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -121.33 139.18 53.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.96 0.41 . . . . 1.0 109.912 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.98 117.42 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.312 -0.995 . . . . 1.0 108.312 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HZ2' ' A' ' 54' ' ' LYS . 71.3 mt -69.65 -50.18 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.3 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -167.75 164.99 14.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.19 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.29 133.06 50.19 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.9 t0 55.1 35.63 25.18 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.32 0.79 6.39 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -93.45 118.94 31.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.96 168.89 19.07 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.08 136.32 26.59 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.27 -38.25 20.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 110.256 -0.275 . . . . 1.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.7 m -144.75 159.03 43.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.93 0.395 . . . . 1.0 110.596 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.94 -37.11 42.29 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.382 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -52.96 -46.0 68.01 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.992 0.425 . . . . 1.0 110.913 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -62.04 -45.34 93.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.828 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.5 -48.29 79.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.44 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.33 -48.12 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.206 -0.665 . . . . 1.0 109.206 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -57.51 -43.26 84.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.585 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -56.86 -48.88 77.08 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.891 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.43 -48.95 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 m 47.9 28.89 1.49 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.287 0.565 . . . . 1.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t 71.31 91.49 0.09 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.079 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -143.1 41.65 1.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.758 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -101.8 175.84 5.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.5 95.21 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.653 -0.703 . . . . 1.0 112.498 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.76 1.87 Allowed Glycine 0 N--CA 1.472 1.089 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -65.83 162.64 18.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -132.53 143.74 49.94 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.59 158.78 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.187 -0.672 . . . . 1.0 109.187 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 42.2 m -104.44 118.14 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 tp -121.62 120.17 34.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HZ2' ' HB ' ' A' ' 25' ' ' ILE . 8.4 mtmp? -92.3 140.16 29.88 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.37 154.65 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.79 129.51 56.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -137.02 105.28 5.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.601 0.36 . . . . 1.0 110.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 47.37 51.54 13.35 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.921 0.391 . . . . 1.0 110.805 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 67.09 31.64 6.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.51 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -129.93 141.49 50.78 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -118.81 144.51 46.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.7 150.68 50.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -129.53 114.78 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.1 t -136.44 137.88 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 118.45 31.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.022 -0.732 . . . . 1.0 109.022 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.44 156.06 48.4 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.565 ' H ' HD13 ' A' ' 66' ' ' LEU . 41.6 m -96.56 126.51 41.79 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.36 161.98 2.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -138.29 171.04 14.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.513 0.673 . . . . 1.0 110.307 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -131.98 148.18 52.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.568 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -39.03 103.87 0.29 Allowed Pre-proline 0 CA--C 1.562 1.436 0 O-C-N 123.994 0.809 . . . . 1.0 110.19 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.97 -10.48 4.26 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.873 1.716 . . . . 1.0 113.493 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 19.7 p-10 -111.2 14.98 21.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.598 0.359 . . . . 1.0 110.483 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -166.99 66.63 0.88 Allowed Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.525 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.15 -17.14 50.34 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.587 1.524 . . . . 1.0 111.831 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.77 -27.05 67.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.671 0.272 . . . . 1.0 110.283 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -128.41 160.15 33.16 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.481 0.657 . . . . 1.0 109.48 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.51 137.88 34.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.862 -1.063 . . . . 1.0 110.605 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.579 ' N ' ' HZ2' ' A' ' 46' ' ' LYS . . . 63.62 142.45 0.02 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.4 tt -64.71 -41.85 93.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.98 22.07 26.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t 55.74 99.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.257 -0.275 . . . . 1.0 110.257 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.1 p -141.31 11.26 2.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.364 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.51 102.18 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.955 -0.387 . . . . 1.0 109.955 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -63.28 144.17 57.17 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -78.75 8.43 5.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.354 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -60.25 -48.05 83.37 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.567 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -69.82 87.08 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.69 -45.39 90.25 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.138 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -168.13 -49.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.172 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.864 -179.779 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 170.55 -94.22 0.1 Allowed Glycine 0 N--CA 1.467 0.748 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -66.56 -16.14 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -145.46 106.12 4.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.365 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -73.65 124.71 26.48 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.0 p -93.89 -32.66 13.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.917 0.389 . . . . 1.0 111.055 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.6 t -172.79 155.18 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.966 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.56 154.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.125 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.6 127.77 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.772 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 81.18 0.29 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.433 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -161.72 18.37 0.1 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.074 -0.391 . . . . 1.0 110.504 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.469 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -123.41 174.37 3.6 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 -178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.801 ' O ' ' N ' ' A' ' 15' ' ' LYS . 77.9 Cg_exo -52.5 -3.18 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.829 2.353 . . . . 1.0 113.267 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 3.11 -44.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.978 1.711 . . . . 1.0 114.51 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.801 ' N ' ' O ' ' A' ' 13' ' ' PRO . 63.8 tttm -50.21 159.93 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.53 -19.43 0.01 OUTLIER Glycine 0 CA--C 1.544 1.883 0 CA-C-O 119.499 -0.612 . . . . 1.0 114.331 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -144.93 102.49 3.78 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.733 1.266 . . . . 1.0 109.042 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -94.75 141.59 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.91 108.51 6.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.6 p -174.66 89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.847 0.832 . . . . 1.0 109.217 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.93 -20.02 10.64 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.043 -1.223 . . . . 1.0 110.043 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -64.73 151.56 44.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.13 -0.535 . . . . 1.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.66 142.75 33.79 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -105.45 119.79 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -67.74 -45.87 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.207 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -169.57 169.03 8.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.877 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.31 136.0 43.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.341 -0.615 . . . . 1.0 109.341 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t70 57.06 38.96 29.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.667 0.27 . . . . 1.0 111.302 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.27 4.88 6.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.522 -0.631 . . . . 1.0 111.522 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -116.6 128.0 54.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.601 0.36 . . . . 1.0 110.248 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -81.96 172.53 13.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 92.5 m-85 -149.24 103.25 3.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.51 -47.32 79.33 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -85.59 125.59 33.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.23 93.58 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.929 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -57.23 -36.48 70.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.311 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -70.2 -40.65 74.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.961 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.0 -52.61 64.29 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.291 -0.256 . . . . 1.0 111.201 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.17 -44.27 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.25 -40.49 96.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.728 -0.215 . . . . 1.0 110.581 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.417 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 56.6 t80 -61.58 -54.69 39.69 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.35 -42.82 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.727 0.269 . . . . 1.0 111.727 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -62.12 -22.66 66.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.784 0.326 . . . . 1.0 111.372 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.1 p -88.18 -0.3 56.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -139.01 46.19 1.96 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.133 0.42 . . . . 1.0 112.133 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -103.9 149.98 24.6 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.423 0.556 . . . . 1.0 109.735 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 65.51 95.28 0.06 Allowed 'General case' 0 C--O 1.231 0.112 0 O-C-N 123.581 0.55 . . . . 1.0 111.501 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.19 12.86 22.71 Favored Glycine 0 N--CA 1.475 1.235 0 CA-C-N 115.541 -0.754 . . . . 1.0 111.241 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -149.78 131.63 15.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.109 0.481 . . . . 1.0 110.669 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 68.2 mttm -93.37 149.06 21.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -149.54 150.73 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.793 -0.818 . . . . 1.0 108.793 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 m -104.9 121.39 43.6 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -120.4 117.67 28.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -87.55 135.31 33.4 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.24 157.31 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -117.84 122.7 44.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.736 -0.838 . . . . 1.0 108.736 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -140.12 124.93 18.3 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 44.49 37.94 2.36 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.465 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 71.44 31.85 2.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.558 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -140.66 158.91 43.28 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 110.156 -0.312 . . . . 1.0 110.156 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -132.18 158.36 41.91 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.989 -0.551 . . . . 1.0 109.832 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.43 152.97 50.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -130.12 125.72 35.81 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.04 136.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.38 114.45 24.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -138.49 161.61 36.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 40.1 m -99.86 140.42 34.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -65.01 -178.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.864 0.364 . . . . 1.0 110.28 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -148.12 171.79 15.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.185 -0.461 . . . . 1.0 109.87 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -133.58 143.72 48.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.338 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -54.79 110.57 2.25 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.34 -54.11 5.95 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 CA-C-N 120.768 1.31 . . . . 1.0 113.623 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.36 -8.95 14.95 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.14 75.84 33.75 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.52 -0.17 10.02 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.414 2.076 . . . . 1.0 111.92 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 19.9 p-10 -89.5 -15.78 32.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.834 -0.432 . . . . 1.0 109.834 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 155.58 46.09 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.051 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 80' ' ' ILE . . . -139.19 147.83 42.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.163 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.5 -34.38 0.98 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.573 -0.611 . . . . 1.0 111.573 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 78' ' ' ALA . 37.2 pt -139.26 151.08 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.596 0.358 . . . . 1.0 110.084 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.63 76.34 0.03 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t 55.15 100.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.612 0.244 . . . . 1.0 110.6 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -62.86 95.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.756 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' HIS . 51.3 mt 56.1 -125.82 2.01 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.571 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 56.1 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.661 0.267 . . . . 1.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 84' ' ' LEU . 72.9 m80 -74.72 65.57 1.36 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.014 0.435 . . . . 1.0 110.125 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.63 -44.82 95.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.01 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.601 ' HD1' ' H ' ' A' ' 90' ' ' HIS . 52.3 t-80 -167.48 167.37 13.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.136 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.438 ' N ' ' CG ' ' A' ' 88' ' ' HIS . 97.4 m-70 -61.14 -43.4 98.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.601 ' H ' ' HD1' ' A' ' 88' ' ' HIS . 42.8 p-80 -162.2 157.75 23.53 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.354 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.063 -0.97 . . . . 1.0 110.529 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.86 -123.89 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.0 mt -64.6 -43.81 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -74.21 144.41 44.73 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.77 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.46 141.64 46.85 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.393 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.7 p -107.24 -37.38 6.28 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.305 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -170.32 163.76 8.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.376 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.25 152.73 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.83 142.2 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.335 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -41.48 152.67 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.026 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 t30 80.59 -148.39 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.088 -2.19 . . . . 1.0 105.088 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.3 mtp 79.44 153.49 0.13 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 124.839 1.256 . . . . 1.0 109.619 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 15' ' ' LYS . 17.8 Cg_endo -48.79 -10.31 0.11 Allowed 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.139 1.892 . . . . 1.0 113.846 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 25.7 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -70.97 108.17 4.42 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.39 -32.92 6.12 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -131.92 108.19 9.22 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 tt -122.19 147.43 26.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -144.31 104.83 4.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.839 -1.171 . . . . 1.0 107.839 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 t -160.1 73.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.87 -17.47 31.37 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.65 163.24 2.59 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.64 133.45 53.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.918 0.39 . . . . 1.0 111.026 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.68 115.12 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -66.57 -47.57 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.259 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t -172.57 168.19 5.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.464 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.2 137.58 50.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.3 p-10 49.88 31.22 4.44 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 5.56 59.86 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.878 -0.489 . . . . 1.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -96.64 114.37 26.01 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 117.079 0.44 . . . . 1.0 110.195 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -69.91 161.69 29.48 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -138.39 125.63 21.63 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.273 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -78.72 -38.7 38.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.766 0.317 . . . . 1.0 110.543 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -144.26 155.56 43.9 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.147 0.498 . . . . 1.0 110.913 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.13 -35.07 15.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.996 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -54.47 -45.22 73.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.961 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -46.94 82.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.34 -49.76 68.99 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.152 -0.343 . . . . 1.0 110.872 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.96 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -56.71 -48.99 76.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.615 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 39.2 t80 -56.51 -52.0 66.41 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.268 -0.27 . . . . 1.0 111.384 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.97 -48.14 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t 45.09 26.31 0.22 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.263 0.554 . . . . 1.0 111.026 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 77.56 91.01 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.255 -0.884 . . . . 1.0 110.05 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -140.36 39.51 1.9 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.31 -0.859 . . . . 1.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -94.4 165.96 12.31 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.46 -0.2 . . . . 1.0 110.46 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.99 101.94 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.8 -59.75 0.35 Allowed Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.892 -0.594 . . . . 1.0 111.742 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.63 151.42 40.83 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.0 -0.37 . . . . 1.0 110.0 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.34 150.77 26.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -148.29 149.54 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -105.59 118.9 37.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.1 tp -115.59 125.4 52.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -99.31 137.29 38.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 56' ' ' GLU . 24.7 mt -140.28 167.17 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.7 tt0 -120.19 126.36 50.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.931 -1.031 . . . . 1.0 109.439 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.93 123.82 22.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 47.68 42.64 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 111.755 0.279 . . . . 1.0 111.755 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.43 -0.42 2.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.689 0.396 . . . . 1.0 111.003 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -106.59 154.96 20.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.97 0.414 . . . . 1.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -122.65 134.75 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.7 145.39 50.2 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -129.46 129.83 45.12 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.82 139.07 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 115.82 28.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.34 161.67 36.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.987 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.5 m -98.46 138.93 34.96 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.9 mp -65.35 158.65 25.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -131.3 164.83 24.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.168 0.587 . . . . 1.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -121.86 144.58 48.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.238 0.615 . . . . 1.0 110.55 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -41.4 140.36 1.28 Allowed Pre-proline 0 CA--C 1.557 1.245 0 CA-C-N 115.588 -0.733 . . . . 1.0 110.812 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.05 -57.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 121.784 1.656 . . . . 1.0 113.525 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.83 14.33 1.11 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -150.39 64.65 6.76 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.22 -14.74 23.08 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.936 1.757 . . . . 1.0 111.639 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.88 -8.61 59.56 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.356 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.06 151.8 51.09 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.271 -0.422 . . . . 1.0 109.937 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.92 141.02 36.54 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.827 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.66 -176.96 47.85 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.8 mt -75.89 124.07 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.6 -171.56 47.8 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.5 145.3 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -62.32 141.0 58.51 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.251 -0.277 . . . . 1.0 110.251 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -82.57 89.1 6.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -63.93 93.44 0.09 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.7 m80 54.18 -175.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.893 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -63.64 -174.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -151.22 147.7 27.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 1.0 110.131 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -60.62 -46.44 90.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 81.6 t60 52.66 78.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.956 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.046 -0.978 . . . . 1.0 111.13 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.39 -149.35 51.14 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -62.27 -8.81 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.677 0.275 . . . . 1.0 110.26 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -107.13 125.27 50.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.392 -0.595 . . . . 1.0 109.392 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 21' ' ' GLY . . . -73.82 149.57 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.083 0.468 . . . . 1.0 110.523 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -146.16 -45.45 0.2 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.74 140.16 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.979 0.419 . . . . 1.0 110.352 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.06 154.37 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.222 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.25 137.19 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.937 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.54 -136.83 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.034 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.06 19.24 10.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.737 0.415 . . . . 1.0 111.686 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.6 mtm -118.91 173.46 3.41 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.4 -22.35 65.42 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 121.884 1.723 . . . . 1.0 111.793 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 45.5 20.17 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.224 -0.898 . . . . 1.0 111.197 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' LYS . 84.1 tttt -54.22 114.86 1.78 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.4 35.11 0.01 OUTLIER Glycine 0 CA--C 1.54 1.655 0 O-C-N 124.057 0.848 . . . . 1.0 113.587 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.6 ptmm? -135.04 123.16 22.83 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -146.41 159.13 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 20' ' ' VAL . 70.2 mt-10 -143.53 107.03 4.58 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 19' ' ' GLU . 16.3 m -159.45 58.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.801 0.81 . . . . 1.0 109.33 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 5' ' ' ALA . . . 105.43 -20.65 36.84 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.372 -1.491 . . . . 1.0 109.372 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.5 153.13 13.41 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -114.2 137.07 52.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.099 0.476 . . . . 1.0 110.72 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -95.21 114.5 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 108.318 -0.993 . . . . 1.0 108.318 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.9 mm -65.84 -49.46 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.911 0.386 . . . . 1.0 110.6 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.7 m -168.11 165.53 13.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.78 -0.646 . . . . 1.0 109.444 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.64 134.85 46.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 t70 56.37 42.79 27.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 1.0 111.327 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.82 9.2 1.66 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 116.258 -0.428 . . . . 1.0 112.154 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -110.81 130.57 55.54 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -87.33 172.86 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 97.8 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.83 -36.01 81.81 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.248 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -101.77 126.91 48.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.377 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.6 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.325 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -54.11 -42.47 69.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 1.0 111.608 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.53 -38.81 85.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.917 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.78 -40.29 96.84 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.972 -0.291 . . . . 1.0 110.246 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.3 -47.79 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.27 -42.81 82.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.6 -46.5 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.757 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.02 -43.12 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.2 t -61.4 -28.21 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 p -69.76 -18.31 63.49 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' HD11 ' A' ' 68' ' ' LEU . 57.1 mtpt -59.19 109.64 0.9 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.997 0.903 . . . . 1.0 111.314 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.645 ' O ' HD12 ' A' ' 68' ' ' LEU . 67.6 mttm -81.75 -164.97 0.87 Allowed 'General case' 0 C--O 1.191 -1.978 0 CA-C-N 114.273 -1.331 . . . . 1.0 110.844 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.21 116.96 33.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.51 -24.97 29.2 Favored Glycine 0 N--CA 1.479 1.549 0 N-CA-C 111.968 -0.453 . . . . 1.0 111.968 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 37.6 t70 -52.01 178.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.075 0.438 . . . . 1.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 21.5 ttpp -138.29 144.92 40.68 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.85 154.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.39 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -105.8 124.29 49.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.84 123.17 42.99 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -91.71 138.07 31.85 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.8 mm -123.91 158.96 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -117.06 127.25 53.97 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.64 120.61 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 41.4 46.58 2.93 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 120.843 0.354 . . . . 1.0 111.725 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.48 31.89 6.02 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -140.03 158.89 43.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -129.27 149.47 51.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.876 0.47 . . . . 1.0 109.967 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -133.91 132.8 40.7 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.829 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -92.04 127.58 37.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.748 -0.464 . . . . 1.0 109.748 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.33 129.92 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.268 0.627 . . . . 1.0 109.635 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.28 116.37 31.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.2 tp -134.85 153.42 52.05 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -97.16 140.47 31.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -54.25 142.18 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -117.46 175.4 5.64 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.526 0.517 . . . . 1.0 109.801 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -129.09 147.24 50.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.845 0.858 . . . . 1.0 109.771 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -64.05 148.99 94.59 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.787 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -67.73 -63.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 122.031 1.82 . . . . 1.0 114.296 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -89.52 12.91 15.19 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -140.83 57.25 7.78 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -70.97 -17.24 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.022 1.814 . . . . 1.0 111.365 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -64.75 -10.23 26.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.579 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -134.06 149.76 51.16 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.696 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -135.55 144.46 46.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.206 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.02 -130.29 10.1 Favored Glycine 0 N--CA 1.475 1.262 0 N-CA-C 110.095 -1.202 . . . . 1.0 110.095 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 81' ' ' GLY . 1.4 pt -93.05 -83.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 116.98 0.39 . . . . 1.0 110.292 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 83' ' ' SER . . . 66.8 64.44 3.29 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.126 -0.789 . . . . 1.0 111.126 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.7 m -73.83 19.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.737 0.303 . . . . 1.0 110.695 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 81' ' ' GLY . 38.6 t -61.59 -16.95 52.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.671 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.43 139.85 58.57 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -167.88 157.06 9.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.728 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' A' ' 88' ' ' HIS . 53.6 t60 -169.06 88.2 0.18 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -61.53 -47.68 84.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 70.2 m80 -65.48 161.87 19.13 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -165.9 139.26 4.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.093 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -65.46 -39.38 91.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.419 -179.768 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.556 ' H1 ' ' H ' ' A' ' 81' ' ' GLY . 26.9 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.92 -160.74 26.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.3 pt -61.76 -10.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.632 0.253 . . . . 1.0 110.574 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -151.0 133.91 15.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -82.62 123.54 29.34 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 t -102.08 -20.35 14.79 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.025 0.44 . . . . 1.0 110.595 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -169.16 154.54 6.03 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -152.48 154.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 123.454 0.471 . . . . 1.0 109.877 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.2 t -91.76 123.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.718 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.67 80.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.615 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -170.88 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.766 -0.197 . . . . 1.0 110.486 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -126.49 -177.02 0.53 Allowed Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 15' ' ' LYS . 87.5 Cg_exo -52.77 -4.08 0.13 Allowed 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.925 2.417 . . . . 1.0 113.81 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 6.7 -51.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.464 1.728 . . . . 1.0 114.101 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.2 tttm -55.47 143.69 28.38 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 -20.8 0.02 OUTLIER Glycine 0 CA--C 1.542 1.731 0 CA-C-N 116.037 -0.528 . . . . 1.0 113.641 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 15' ' ' LYS . 12.0 tmtt? -142.77 107.66 4.9 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.38 151.54 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 123.521 0.513 . . . . 1.0 110.039 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -142.81 111.31 6.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.547 -0.751 . . . . 1.0 109.364 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 20' ' ' VAL . 14.6 p -174.86 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 79.68 -18.5 7.18 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.801 -1.319 . . . . 1.0 109.801 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' VAL . 78.0 m-20 -71.94 157.13 38.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -112.2 152.56 28.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.365 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.76 119.82 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.45 -45.53 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.837 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.0 p -159.77 159.46 32.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.013 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -127.88 97.07 4.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.351 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.0 t70 45.9 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.035 0.445 . . . . 1.0 111.784 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.1 -119.03 0.46 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 54.4 mtpt -108.61 175.82 5.33 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.908 0.483 . . . . 1.0 111.192 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.36 -14.74 61.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.487 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 70.6 m-85 50.79 101.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.986 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -58.82 -44.98 90.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.632 0.253 . . . . 1.0 110.623 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -85.12 126.58 33.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.842 0.353 . . . . 1.0 110.055 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.68 88.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.569 . . . . 1.0 111.172 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -53.02 -38.51 62.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.731 0.3 . . . . 1.0 111.307 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -63.85 -42.5 97.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.528 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.49 -46.01 88.07 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.395 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.27 -50.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 120.592 -0.443 . . . . 1.0 109.937 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' CG ' ' HE2' ' A' ' 86' ' ' HIS . 79.5 m-20 -59.91 -36.9 77.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.643 -0.253 . . . . 1.0 110.767 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.63 -46.19 89.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.586 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -63.59 -45.8 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t 51.9 20.33 1.18 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.673 0.749 . . . . 1.0 110.598 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t 67.11 10.33 7.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.269 -0.878 . . . . 1.0 111.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -65.63 58.41 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.292 0.37 . . . . 1.0 111.295 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 98.5 mttt -103.0 153.71 19.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 81.49 93.73 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.796 0.438 . . . . 1.0 110.158 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.51 -57.89 0.45 Allowed Glycine 0 N--CA 1.474 1.214 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.47 140.39 49.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -110.89 147.31 34.88 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 68' ' ' LEU . 14.6 m -156.74 161.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -103.77 121.88 43.94 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.68 148.81 33.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.569 -0.901 . . . . 1.0 108.569 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -121.56 133.55 55.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.714 -1.13 . . . . 1.0 109.504 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 mm -118.47 148.47 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -114.33 122.81 47.84 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.47 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -134.95 112.96 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 44.3 42.1 4.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.22 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 67.73 33.3 4.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.909 0.755 . . . . 1.0 111.12 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -126.98 102.3 6.93 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -84.96 146.62 27.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.56 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -135.54 151.51 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -130.3 121.74 26.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.6 t -138.03 135.24 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.1 m -89.71 116.22 27.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -139.54 164.27 30.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.132 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -101.9 139.95 36.85 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 51' ' ' VAL . 94.4 mt -53.07 173.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.686 0.279 . . . . 1.0 110.858 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -146.38 154.09 41.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.934 0.397 . . . . 1.0 110.614 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -131.1 141.79 50.19 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.611 -0.722 . . . . 1.0 111.098 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -51.33 140.04 25.06 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.71 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.11 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.769 1.646 . . . . 1.0 112.851 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 23.6 p-10 -66.25 -5.76 11.48 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.585 0.217 . . . . 1.0 111.585 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -138.14 74.89 41.87 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.41 -5.31 13.4 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.399 2.066 . . . . 1.0 111.4 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.16 -19.72 26.56 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.177 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.34 151.73 46.61 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.97 149.7 45.03 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.712 -0.477 . . . . 1.0 109.712 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.56 130.96 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.574 -1.01 . . . . 1.0 110.574 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.33 -48.17 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' H1 ' ' A' ' 1' ' ' ASN . . . 61.4 154.38 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.9 -72.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.0 p -163.82 163.43 23.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.198 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.17 170.34 2.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.251 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -168.09 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.419 ' HE2' ' CG ' ' A' ' 40' ' ' ASP . 97.1 m-70 -64.0 122.13 15.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.231 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.21 77.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -162.42 156.44 21.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 81.8 t60 54.49 14.53 0.83 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -60.05 -44.85 94.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.967 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 61.87 -133.37 46.66 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.77 -0.932 . . . . 1.0 110.77 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.75 15.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 122.752 -0.264 . . . . 1.0 110.668 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 2' ' ' GLY . 17.4 t80 -158.29 109.1 2.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.98 -0.288 . . . . 1.0 110.528 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.98 101.99 4.0 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.742 0.306 . . . . 1.0 110.614 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -99.16 -8.25 25.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.32 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.5 t -170.0 168.92 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.899 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -142.36 137.32 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.91 136.56 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.3 pm0 -84.06 44.92 1.04 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.299 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -154.5 25.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 121.176 -0.209 . . . . 1.0 111.544 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mmm -135.69 158.87 73.3 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.634 -1.247 . . . . 1.0 107.634 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' LYS . 31.2 Cg_exo -63.34 -29.26 72.3 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 CA-C-N 121.327 1.51 . . . . 1.0 113.879 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 37.03 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.59 0.756 . . . . 1.0 112.053 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 17' ' ' LYS . 87.7 tttt -77.61 123.79 27.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.178 0.591 . . . . 1.0 110.175 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 64.7 -21.61 0.1 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.557 -0.617 . . . . 1.0 111.557 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 15' ' ' LYS . 68.3 mttm -68.82 -164.47 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 pt -62.93 152.74 7.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.706 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' H ' ' HB2' ' A' ' 22' ' ' ASP . 2.9 tp10 -123.88 -178.4 4.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.814 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -72.5 108.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.404 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.79 67.64 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.779 -0.528 . . . . 1.0 111.779 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 19' ' ' GLU . 8.2 m-20 -66.54 153.81 42.01 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.05 0.925 . . . . 1.0 110.348 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -118.47 146.84 44.18 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.221 -0.899 . . . . 1.0 109.517 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -101.72 109.78 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.45 -43.11 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.028 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 m -165.34 167.66 17.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.825 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.8 119.45 26.9 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 55.67 31.32 17.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.851 0.358 . . . . 1.0 111.499 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.29 -8.37 64.52 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -92.55 139.29 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -119.05 154.55 32.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.165 0.586 . . . . 1.0 109.574 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -149.01 117.04 6.34 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.018 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -64.65 -43.7 92.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.094 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 p -85.35 133.67 34.13 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.831 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.48 87.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.689 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -54.02 -41.85 68.47 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.153 0.501 . . . . 1.0 111.615 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -64.45 -41.91 96.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.016 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.41 -43.29 94.83 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.157 -0.312 . . . . 1.0 110.157 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.19 -46.82 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.49 -34.95 77.87 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.836 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -59.01 -42.35 89.9 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -62.99 -43.18 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 55.83 24.0 7.0 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.273 0.559 . . . . 1.0 111.148 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 46' ' ' LYS . 4.8 t 64.0 11.79 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.404 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -65.68 58.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 1.0 110.537 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 63.8 mttp -104.38 155.26 18.93 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . 85.41 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.028 0.531 . . . . 1.0 111.114 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.42 -50.21 0.9 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.69 151.66 46.94 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -131.29 152.34 50.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.42 160.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -100.5 121.2 41.18 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.161 -0.681 . . . . 1.0 109.161 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -112.67 126.43 55.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mm -118.77 148.15 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.28 0.632 . . . . 1.0 109.666 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -116.6 125.79 52.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.555 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -135.53 111.98 9.89 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 46.78 44.52 14.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.729 -0.214 . . . . 1.0 111.285 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 64.15 33.48 11.83 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.764 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -134.72 113.37 11.59 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -85.88 140.72 30.15 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -135.6 113.58 11.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -88.85 119.65 29.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.913 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.65 134.62 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.2 m -91.65 117.58 29.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' H ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -133.28 160.48 37.18 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.541 ' H ' HD13 ' A' ' 66' ' ' LEU . 60.5 m -105.49 134.88 47.87 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.5 mp -57.47 168.1 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.806 0.336 . . . . 1.0 110.226 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -147.58 165.55 30.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.445 0.64 . . . . 1.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.541 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -132.59 138.98 47.62 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.22 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -52.08 112.21 3.1 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.679 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.06 -52.34 6.52 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 121.626 1.551 . . . . 1.0 113.886 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 15.2 p-10 -58.31 -4.52 0.38 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.07 77.32 20.69 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.64 -11.88 16.87 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.631 1.554 . . . . 1.0 111.391 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -90.53 -18.27 25.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.534 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -134.33 146.57 50.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.76 0.424 . . . . 1.0 109.897 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.09 155.06 46.19 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.987 0.422 . . . . 1.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.61 -173.77 11.9 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.6 tp -155.56 149.38 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 109.752 -0.462 . . . . 1.0 109.752 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.48 -120.94 0.58 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.31 -0.716 . . . . 1.0 111.31 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 131.29 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.8 t -67.99 152.64 45.21 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.4 mp -67.7 139.6 56.74 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -76.89 17.99 0.39 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 84' ' ' LEU . 59.6 t-80 -58.43 100.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.797 0.332 . . . . 1.0 110.546 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.31 136.71 55.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.246 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -69.18 141.35 54.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.177 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.78 -40.63 93.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.75 152.12 43.43 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.4 m80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.068 -0.967 . . . . 1.0 110.579 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 61.24 -98.72 0.18 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.9 pt -72.93 11.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.312 -0.255 . . . . 1.0 110.312 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.406 ' H ' ' C ' ' A' ' 2' ' ' GLY . 26.9 t80 -156.61 107.49 2.39 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.804 0.335 . . . . 1.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.14 131.09 41.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.998 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -127.18 -22.89 3.66 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 1.0 109.897 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -167.62 168.58 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.64 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -136.95 129.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 10' ' ' GLU . 27.1 m -55.59 151.17 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.117 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' VAL . 15.4 pt-20 -38.67 171.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.106 0.879 . . . . 1.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 59.79 -104.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.5 tpp 41.28 97.3 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 123.087 0.555 . . . . 1.0 111.369 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' LYS . 63.4 Cg_exo -53.5 -12.54 2.85 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.64 1.56 . . . . 1.0 112.55 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.13 18.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.415 1.072 . . . . 1.0 111.464 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 17' ' ' LYS . 63.5 tttp -77.92 132.73 38.03 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 122.927 0.491 . . . . 1.0 110.035 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.78 -8.52 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.293 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.4 ptmt -130.47 110.23 11.3 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tp -114.77 135.2 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 20' ' ' VAL . 71.8 mt-10 -142.21 105.28 4.59 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -170.34 90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.25 -16.73 21.75 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 110.237 -1.145 . . . . 1.0 110.237 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.68 170.95 13.44 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -121.81 148.31 44.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.699 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -97.75 110.91 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.7 tt -65.1 -41.09 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.032 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.4 p -157.99 155.71 29.88 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' GLY . . . -130.46 95.47 3.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 50.55 11.97 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.847 0.356 . . . . 1.0 111.711 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ALA . . . -165.48 -118.15 0.43 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.374 -1.09 . . . . 1.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 20.6 mtpp -106.4 177.15 4.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.202 0.525 . . . . 1.0 111.489 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -69.15 -17.77 63.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.472 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 30' ' ' LYS . 65.6 m-85 51.57 103.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.86 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -58.15 -43.37 87.31 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.743 0.306 . . . . 1.0 110.431 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.7 m -92.85 112.61 24.63 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.047 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.05 44.4 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.934 0.397 . . . . 1.0 111.061 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -54.29 -40.07 67.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.762 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -63.69 -44.83 92.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.821 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.9 tt -60.22 -49.31 78.12 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.996 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.64 -49.0 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.98 -40.4 93.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.791 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -61.1 -53.69 53.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.205 -0.31 . . . . 1.0 111.672 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 -40.29 88.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.868 -0.419 . . . . 1.0 109.868 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m 52.87 30.51 9.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.795 0.807 . . . . 1.0 110.025 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' LYS . 16.4 m 55.58 12.44 0.79 Allowed 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.596 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -56.85 68.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.934 0.772 . . . . 1.0 111.392 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.5 mttm -97.96 157.56 16.04 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 122.931 0.492 . . . . 1.0 109.818 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.02 91.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.07 -61.64 0.52 Allowed Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.663 -0.575 . . . . 1.0 111.663 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.49 139.73 39.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.556 0.217 . . . . 1.0 110.515 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' NZ ' ' OG1' ' A' ' 67' ' ' THR . 65.0 mttm -100.16 149.03 23.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.5 143.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -98.1 114.98 27.33 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 mt -113.02 109.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.24 144.17 26.94 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.58 151.27 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -110.44 122.36 47.53 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -137.29 119.41 15.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 42.03 43.51 2.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.969 0.359 . . . . 1.0 111.969 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 69.48 33.01 3.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 1.0 111.829 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.21 149.77 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.73 147.75 52.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -138.46 146.8 42.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.04 135.01 47.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.213 0.605 . . . . 1.0 109.76 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.1 143.04 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 65' ' ' THR . 9.4 t -88.41 115.26 25.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tp -135.74 164.46 27.85 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.817 -0.628 . . . . 1.0 109.843 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 20.6 m -110.32 136.87 48.84 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.62 155.09 23.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -100.86 179.21 4.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.004 0.522 . . . . 1.0 110.871 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.38 147.36 49.2 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.367 0.667 . . . . 1.0 110.362 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -54.17 110.16 1.95 Allowed Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 119.118 -0.468 . . . . 1.0 110.169 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -53.06 -38.95 81.08 Favored 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 121.45 1.433 . . . . 1.0 113.575 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -87.89 19.54 3.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.322 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -168.49 64.95 0.63 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.38 -9.59 24.41 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.881 1.721 . . . . 1.0 111.881 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -79.3 -9.54 59.61 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.759 0.314 . . . . 1.0 110.44 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -144.11 162.92 35.03 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.21 145.85 39.79 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 159.27 0.42 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.4 mt 56.55 84.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.692 0.282 . . . . 1.0 110.296 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.15 131.39 33.13 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 84' ' ' LEU . 21.2 t -78.26 132.68 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 t -71.1 14.64 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.758 0.314 . . . . 1.0 110.917 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 82' ' ' VAL . 5.0 tp 60.22 34.6 21.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.028 0.442 . . . . 1.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -167.51 92.93 0.4 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.023 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -167.42 -59.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.022 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -62.21 155.75 23.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.507 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 89' ' ' HIS . 4.9 p80 -168.16 -15.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.155 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 88' ' ' HIS . 58.9 t-80 -61.56 -47.17 86.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.365 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -168.09 160.46 11.89 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.938 0.399 . . . . 1.0 110.412 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.049 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.52 -141.71 47.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.34 0.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.592 0.234 . . . . 1.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.6 137.03 52.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.31 109.21 21.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 110.382 -0.229 . . . . 1.0 110.382 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -87.73 -30.75 20.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.627 0.251 . . . . 1.0 111.157 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.5 p -165.98 165.15 18.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 m -153.32 156.55 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -114.05 143.0 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.55 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.46 32.81 19.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -123.16 163.08 35.91 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 15' ' ' LYS . 32.5 Cg_exo -62.49 -24.43 75.39 Favored 'Trans proline' 0 N--CA 1.51 2.464 0 C-N-CA 121.673 1.582 . . . . 1.0 113.569 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 39.87 22.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 123.636 0.585 . . . . 1.0 111.374 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 17' ' ' LYS . 34.0 ttmt -63.46 124.88 22.46 Favored 'General case' 0 N--CA 1.461 0.09 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 23.54 41.17 0.01 OUTLIER Glycine 0 N--CA 1.481 1.645 0 O-C-N 124.265 0.978 . . . . 1.0 113.321 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' LYS . 19.8 ptmt -142.49 131.69 23.36 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.039 -1.097 . . . . 1.0 108.039 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -136.25 153.48 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -138.14 -168.31 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.489 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t 77.07 95.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 124.065 0.853 . . . . 1.0 109.552 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.22 -29.3 7.18 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.565 -1.014 . . . . 1.0 110.565 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.71 176.7 6.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -137.06 155.26 49.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.94 125.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 mm -71.77 -59.1 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.75 0.31 . . . . 1.0 110.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -154.91 150.54 27.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -85.95 -95.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.247 0.546 . . . . 1.0 112.449 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.55 47.13 1.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.574 . . . . 1.0 111.84 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.55 31.71 56.03 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.411 -0.676 . . . . 1.0 111.411 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.71 113.41 14.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.646 0.379 . . . . 1.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -89.58 86.23 6.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.71 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -67.53 129.72 40.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.346 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -79.56 -17.17 54.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.745 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -131.35 121.31 24.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.691 0.397 . . . . 1.0 110.542 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.93 23.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.67 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -57.03 -41.8 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 1.0 110.258 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -61.72 -44.6 96.6 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.943 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -56.04 -43.67 78.06 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.25 -0.281 . . . . 1.0 110.249 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.48 -46.09 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -59.93 -47.23 86.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.375 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -60.33 -54.33 46.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 44' ' ' SER . 17.9 tt -66.03 -40.89 88.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.138 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p 44.53 37.15 1.98 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.648 0.737 . . . . 1.0 110.546 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 42' ' ' ILE . 5.9 p 81.29 -54.1 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.993 -1.458 . . . . 1.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 68' ' ' LEU . 97.6 mttt 16.0 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.558 1.143 . . . . 1.0 113.201 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' A' ' 68' ' ' LEU . 33.1 mttm -95.23 170.98 9.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.837 0.455 . . . . 1.0 110.415 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.18 119.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.07 0.462 . . . . 1.0 111.712 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.77 -62.68 4.2 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.56 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.87 148.1 52.33 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.67 173.5 6.39 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 68' ' ' LEU . 7.9 p -165.2 161.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.96 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 27' ' ' ALA . 86.5 m -115.49 111.41 20.71 Favored 'General case' 0 C--O 1.211 -0.929 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 mp -121.38 125.07 46.06 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -105.92 150.2 25.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -121.32 150.54 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -109.31 129.48 55.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.744 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -139.48 100.25 3.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.236 0.541 . . . . 1.0 110.126 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 52.31 58.91 4.91 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.289 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 65.69 34.15 7.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.17 0.433 . . . . 1.0 112.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.77 160.21 30.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.31 145.71 43.76 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -136.26 146.63 46.92 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -128.33 125.18 38.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.88 151.69 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 m -117.12 117.93 30.97 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 161.37 37.13 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.123 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -83.94 136.12 34.2 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.852 -0.796 . . . . 1.0 108.852 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 HG11 ' A' ' 51' ' ' VAL . 40.0 mt -58.87 155.04 13.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -127.66 159.52 34.45 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.802 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -133.55 147.11 51.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 1.0 110.289 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.409 ' N ' HD11 ' A' ' 80' ' ' ILE . 53.5 m-85 -44.22 143.43 1.92 Allowed Pre-proline 0 CA--C 1.563 1.449 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.734 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.54 -59.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.938 1.759 . . . . 1.0 114.515 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.38 12.84 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.909 0.385 . . . . 1.0 111.947 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.11 65.56 13.73 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.61 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.48 -9.66 25.55 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 121.764 1.643 . . . . 1.0 111.407 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -87.88 -0.82 57.47 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.129 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -148.75 152.74 37.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.41 144.75 34.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' GLY . . . 166.77 54.02 0.03 OUTLIER Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 71' ' ' PHE . 33.3 mm -62.99 78.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 110.249 -0.278 . . . . 1.0 110.249 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 79' ' ' GLY . . . 133.95 17.71 1.02 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -157.71 146.14 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.871 0.367 . . . . 1.0 110.317 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 t -163.02 137.22 6.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 mt -69.41 139.38 54.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.31 178.36 0.54 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.39 113.3 3.55 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.18 -44.23 92.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.4 t60 52.21 86.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.006 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -168.72 86.8 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -165.98 138.07 3.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.841 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.124 -0.941 . . . . 1.0 110.508 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.81 -133.82 0.01 OUTLIER Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 mm -64.72 -43.97 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -75.99 149.29 37.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.202 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.28 128.51 35.86 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -81.56 -71.96 0.45 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.6 t -162.89 136.76 6.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.216 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.8 144.1 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -50.76 140.32 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.977 0.418 . . . . 1.0 110.857 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -94.56 96.3 9.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -147.94 32.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 1.0 110.397 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.54 174.96 4.09 Favored Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.303 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -58.79 -25.2 75.24 Favored 'Trans proline' 0 N--CA 1.505 2.19 0 C-N-CA 122.526 2.151 . . . . 1.0 112.186 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 44.16 16.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.156 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' LYS . 87.1 tttt -64.87 133.38 51.75 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 37.32 17.65 0.01 OUTLIER Glycine 0 CA--C 1.548 2.137 0 O-C-N 123.419 0.449 . . . . 1.0 113.582 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' LYS . 11.5 ptmm? -142.66 129.92 21.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.712 -1.218 . . . . 1.0 107.712 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -141.85 155.91 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.717 -1.216 . . . . 1.0 107.717 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -145.55 100.9 3.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.362 -1.347 . . . . 1.0 107.362 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -163.15 83.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 84.82 -23.22 7.92 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -64.91 161.22 18.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -113.15 138.22 50.28 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.747 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -94.0 118.12 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.683 -1.229 . . . . 1.0 107.683 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.52 -53.37 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.84 0.352 . . . . 1.0 110.2 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.6 p -171.01 166.03 7.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.985 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.02 135.83 45.66 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER 66.81 4.72 3.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.462 0.305 . . . . 1.0 111.644 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 35.36 8.54 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.874 -0.891 . . . . 1.0 110.874 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -141.78 125.81 17.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.751 0.31 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.05 165.43 24.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -145.02 135.96 24.73 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 110.086 -0.339 . . . . 1.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.0 -83.59 0.07 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.95 -0.389 . . . . 1.0 109.95 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -83.49 143.52 30.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.942 0.401 . . . . 1.0 111.062 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.56 -25.5 10.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.874 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -56.38 -41.91 76.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.635 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.57 -46.26 80.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.358 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.37 -46.82 85.57 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.514 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -63.66 -46.34 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -62.38 -38.85 91.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.422 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -58.37 -47.97 82.12 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 122.36 -0.213 . . . . 1.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -62.15 -42.14 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.9 t 52.25 26.32 3.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.511 0.672 . . . . 1.0 111.036 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 46' ' ' LYS . 3.5 p 73.56 10.21 4.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.329 -0.85 . . . . 1.0 111.807 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.75 58.27 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.255 0.347 . . . . 1.0 110.753 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.8 mttm -107.42 162.93 13.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 79.81 103.49 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.059 0.457 . . . . 1.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -59.52 2.17 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.7 134.19 52.69 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -98.61 169.71 9.32 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 p -167.38 165.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.632 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 51' ' ' VAL . 19.5 m -111.1 115.89 30.2 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.2 mt -113.78 122.33 46.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -100.95 143.71 30.78 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.84 155.77 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -118.85 129.26 55.12 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.298 -0.865 . . . . 1.0 109.686 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -132.86 98.2 4.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 51.9 56.71 7.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.894 -0.593 . . . . 1.0 111.145 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 66.56 33.25 6.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.509 0.559 . . . . 1.0 112.509 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.43 109.77 10.97 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 110.099 -0.334 . . . . 1.0 110.099 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -84.86 151.47 24.27 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -141.53 130.57 23.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -95.05 124.28 39.01 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.94 149.61 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 m -126.32 117.62 23.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.3 154.33 51.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.535 0.683 . . . . 1.0 110.465 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.6 m -85.28 136.81 33.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.482 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.28 150.66 46.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.922 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -130.29 169.01 15.98 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.313 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.32 145.25 48.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.335 0.654 . . . . 1.0 110.287 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.28 146.76 60.94 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.471 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.14 -73.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 121.711 1.607 . . . . 1.0 113.188 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.6 -7.4 3.27 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.888 0.329 . . . . 1.0 111.888 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -130.91 72.5 81.82 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.28 -11.38 10.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.331 2.021 . . . . 1.0 112.045 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -92.7 1.23 57.38 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.482 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.44 150.87 45.72 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.45 140.47 37.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.123 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.1 -174.18 49.72 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.73 142.94 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.764 0.316 . . . . 1.0 110.599 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.91 73.89 0.04 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.702 -0.959 . . . . 1.0 110.702 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.38 163.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 122.701 0.4 . . . . 1.0 110.415 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 p 54.68 23.25 4.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.172 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.77 -41.95 99.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.422 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -68.58 155.97 38.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -158.65 22.5 0.22 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.204 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -59.98 -39.0 84.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.379 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CG ' ' H ' ' A' ' 89' ' ' HIS . 19.8 t60 56.17 -179.17 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 88' ' ' HIS . 93.4 m-70 53.65 80.33 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.807 0.337 . . . . 1.0 110.809 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -64.84 -39.4 93.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.255 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.189 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.76 -142.0 48.2 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 24' ' ' ILE . 55.7 mt -65.24 -43.08 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -60.66 -155.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.49 130.53 20.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.584 -0.525 . . . . 1.0 109.584 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.2 t -92.42 -43.74 9.05 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.715 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.0 p -171.54 153.55 3.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.45 154.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.128 0.49 . . . . 1.0 110.432 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.38 134.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.189 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.23 -150.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.93 23.3 13.29 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.672 0.389 . . . . 1.0 111.708 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtm -123.28 -179.66 0.86 Allowed Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 15' ' ' LYS . 75.8 Cg_exo -56.82 -16.34 19.62 Favored 'Trans proline' 0 N--CA 1.505 2.191 0 C-N-CA 122.583 2.188 . . . . 1.0 113.017 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 22.14 -55.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.571 1.693 . . . . 1.0 115.571 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.8 tttt -61.04 107.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.85 -25.5 7.94 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -136.36 110.88 8.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.68 137.45 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -140.73 107.14 5.27 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.3 p -175.15 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.27 -23.84 6.81 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.383 -1.087 . . . . 1.0 110.383 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.44 158.25 9.89 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -105.58 135.45 46.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.259 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -96.38 114.08 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.75 -48.41 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -169.13 164.4 11.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.272 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.46 134.74 50.87 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.517 -0.92 . . . . 1.0 108.517 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 1.9 p-10 47.07 36.74 4.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.78 -1.76 36.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.125 -0.559 . . . . 1.0 111.785 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -94.03 121.11 35.17 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -91.6 139.87 30.27 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.32 131.68 46.97 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -101.54 1.78 38.34 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.54 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -144.31 136.85 26.73 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.046 0.45 . . . . 1.0 110.768 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.83 78.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 1.0 111.234 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.73 -43.42 72.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.247 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -63.79 -43.6 95.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.049 -0.26 . . . . 1.0 110.419 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -58.0 -45.43 86.82 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.022 -0.424 . . . . 1.0 110.349 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.93 -46.92 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -54.68 -45.19 73.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.735 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CE2' ' OD1' ' A' ' 28' ' ' ASP . 27.4 t80 -57.79 -49.54 76.26 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 122.295 -0.253 . . . . 1.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -49.59 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 44.31 23.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.267 0.556 . . . . 1.0 111.044 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p 74.56 94.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.364 -0.835 . . . . 1.0 108.976 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -139.28 40.02 2.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.525 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.5 mttt -99.5 164.07 12.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.956 -0.465 . . . . 1.0 110.724 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 76.72 92.97 0.07 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 1.0 112.433 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.67 -50.38 0.83 Allowed Glycine 0 N--CA 1.473 1.122 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.575 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -71.43 144.23 49.83 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.746 -0.465 . . . . 1.0 109.746 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -111.62 154.52 24.75 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 52' ' ' THR . 7.4 p -163.93 161.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.156 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 51' ' ' VAL . 28.6 m -110.54 124.19 51.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -110.59 125.71 53.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.83 128.64 40.2 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.287 -0.635 . . . . 1.0 109.287 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.6 mm -123.39 153.53 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.77 127.3 54.99 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.451 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -138.58 119.08 13.84 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 42.03 47.38 3.84 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 1.0 111.873 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 65.52 30.89 10.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.925 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -135.34 156.37 49.05 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -127.32 157.13 40.72 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.757 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -127.31 150.09 49.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 1.0 110.314 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -129.46 113.79 15.33 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.3 136.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -97.7 116.73 30.49 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.0 163.28 31.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.133 0.573 . . . . 1.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.6 t -97.52 136.5 37.85 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.0 171.16 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.187 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.71 158.03 43.83 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.825 0.345 . . . . 1.0 110.769 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -123.96 144.53 49.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.239 0.616 . . . . 1.0 111.044 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -47.4 138.36 8.54 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.7 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.697 1.598 . . . . 1.0 113.458 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.77 4.62 6.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -151.27 71.13 8.43 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.83 -3.76 11.24 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.468 2.112 . . . . 1.0 111.186 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -78.3 -19.29 53.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.266 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -135.86 151.29 49.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.075 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -140.92 150.84 43.67 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.219 0.533 . . . . 1.0 110.747 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.63 -119.05 5.97 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 82' ' ' VAL . 66.5 mt -63.31 -45.64 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 -34.15 1.07 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 80' ' ' ILE . 25.8 t 53.17 84.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.72 0.295 . . . . 1.0 110.97 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -63.17 150.16 43.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.181 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -167.58 45.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.972 0.415 . . . . 1.0 109.933 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -71.44 3.07 4.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.224 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 55.01 -167.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.629 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.0 m80 54.24 98.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.583 -0.281 . . . . 1.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -59.76 -40.41 88.08 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.581 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.69 146.92 22.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.028 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -66.62 -40.54 88.82 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.06 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.555 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.77 -109.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 3' ' ' ILE . 3.9 mp -63.63 -43.84 98.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.15 -154.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.412 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.43 167.06 25.37 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.049 0.452 . . . . 1.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -158.66 -48.33 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.9 t -174.91 120.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.337 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.83 151.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.082 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.59 142.63 16.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.997 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' SD ' ' A' ' 12' ' ' MET . 38.9 tt0 -91.24 -112.96 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.33 14.91 7.47 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.161 0.585 . . . . 1.0 111.118 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -124.92 176.93 2.07 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' LYS . 88.0 Cg_exo -53.56 -34.0 70.87 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 121.726 1.617 . . . . 1.0 112.892 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.01 -37.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.327 1.017 . . . . 1.0 112.771 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' PRO . 63.6 tttm -65.15 108.27 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.511 -0.118 . . . . 1.0 111.204 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -25.77 21.21 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.95 108.61 6.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.32 158.89 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.07 105.42 3.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.548 -1.279 . . . . 1.0 107.548 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.7 t -156.62 74.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.03 -26.44 6.78 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.211 -1.155 . . . . 1.0 110.211 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -53.48 157.08 2.22 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.874 -0.192 . . . . 1.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.13 132.62 53.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -103.39 123.24 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.71 -51.47 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.172 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 t -177.76 158.39 1.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.008 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.35 140.34 48.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.47 33.39 22.44 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.521 0.2 . . . . 1.0 111.049 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.72 9.7 7.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -111.85 123.66 50.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.862 0.363 . . . . 1.0 110.058 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -78.73 165.19 23.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 34' ' ' SER . 98.6 m-85 -141.27 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.176 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 65.31 -23.19 0.09 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.621 0.576 . . . . 1.0 111.331 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 32' ' ' TYR . 49.3 m -103.64 119.01 38.05 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.617 0.367 . . . . 1.0 110.074 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.27 81.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.223 0.535 . . . . 1.0 111.431 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.14 -42.67 69.79 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.615 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -69.01 -49.98 52.95 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.949 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.22 -47.57 85.47 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.756 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -62.6 -48.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 1.0 109.989 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -67.3 -36.46 81.56 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.201 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -62.11 -55.16 31.71 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.147 -0.221 . . . . 1.0 111.582 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 43' ' ' SER . 18.1 tt -69.87 -43.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.75 0.309 . . . . 1.0 111.14 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 42' ' ' ILE . 35.7 t -61.59 -32.74 72.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.465 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -80.98 -2.09 46.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -135.36 44.61 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.712 -0.222 . . . . 1.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -95.03 157.75 15.76 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.71 107.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.96 -54.41 1.02 Allowed Glycine 0 N--CA 1.47 0.913 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.492 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.86 141.29 58.31 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -113.73 150.4 33.41 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 52' ' ' THR . 4.2 p -163.76 161.87 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 51' ' ' VAL . 16.1 m -102.87 128.28 49.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.48 124.33 47.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.874 -0.788 . . . . 1.0 108.874 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -92.55 133.14 36.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' GLU . 17.8 mm -130.83 164.5 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.9 tt0 -131.05 135.03 47.2 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.507 -0.77 . . . . 1.0 109.203 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.588 HH21 ' NZ ' ' A' ' 62' ' ' LYS . 71.6 mtm180 -143.72 126.33 15.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 41.02 42.72 1.63 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.608 0.242 . . . . 1.0 111.441 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 67.54 30.58 6.63 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.935 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' ARG . 61.4 mttp -137.43 122.36 18.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.936 0.398 . . . . 1.0 110.012 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -94.49 147.45 23.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.588 ' NZ ' HH21 ' A' ' 57' ' ' ARG . 34.7 mmtp -130.26 151.8 50.37 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -130.16 117.22 19.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.713 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.33 136.5 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' THR . 9.7 t -99.35 115.74 29.92 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -138.89 165.58 26.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.064 0.545 . . . . 1.0 109.776 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.8 m -102.59 133.68 47.18 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 68' ' ' LEU . 8.1 mp -62.14 173.58 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.303 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -138.61 173.68 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -133.86 149.37 51.35 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.089 -0.959 . . . . 1.0 109.942 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -43.35 108.92 0.72 Allowed Pre-proline 0 CA--C 1.561 1.38 0 O-C-N 123.514 0.509 . . . . 1.0 110.039 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.96 -51.29 10.17 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 121.552 1.501 . . . . 1.0 113.666 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -77.77 16.29 0.71 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.699 0.285 . . . . 1.0 111.47 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -164.92 70.85 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.303 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 -8.29 18.32 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.151 1.901 . . . . 1.0 111.439 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.23 -21.22 56.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.447 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -135.23 154.05 51.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.15 143.6 40.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.046 0.451 . . . . 1.0 110.278 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.19 155.49 0.97 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.5 pt -63.49 177.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.842 0.353 . . . . 1.0 110.52 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.87 55.43 0.07 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.74 92.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -71.59 -18.39 62.23 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.415 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.4 mt -62.95 -40.56 98.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.209 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 54.47 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.452 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 68.8 m80 53.88 -178.4 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.808 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -64.4 -43.91 92.93 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.768 0.318 . . . . 1.0 110.171 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -63.59 144.35 57.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.175 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.98 118.46 0.81 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 51.65 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.205 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.154 -179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.87 75.51 0.25 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.6 pt 36.78 30.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.507 0.558 . . . . 1.0 112.507 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -158.42 114.01 2.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.52 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.81 165.74 24.58 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.7 p -167.18 -46.45 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.765 0.316 . . . . 1.0 110.498 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -171.78 115.21 0.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.153 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.5 150.84 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.8 0.44 . . . . 1.0 109.981 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.65 143.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.292 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -98.93 105.74 17.92 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.654 0.264 . . . . 1.0 110.703 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 71' ' ' PHE . 9.2 p-10 -150.58 20.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.082 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.77 176.25 3.03 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' LYS . 64.1 Cg_exo -59.6 -29.15 89.16 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.339 2.026 . . . . 1.0 112.802 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 48.21 11.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.245 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.5 tttp -78.78 116.47 19.15 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 121.081 0.467 . . . . 1.0 111.168 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 -8.77 4.5 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.912 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -134.46 106.65 7.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -130.91 156.18 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.992 0.425 . . . . 1.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -138.51 105.18 5.34 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.2 t -159.34 77.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.23 -18.1 38.84 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 110.386 -1.086 . . . . 1.0 110.386 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.52 154.23 25.27 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -110.56 141.53 43.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.214 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 126.84 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.472 HD12 ' HZ2' ' A' ' 54' ' ' LYS . 73.8 mt -83.92 -46.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.3 p -166.99 159.27 13.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.132 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.75 134.33 55.02 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 56.64 34.49 24.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.622 0.249 . . . . 1.0 111.131 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.38 -1.52 5.17 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.83 126.93 43.45 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.854 0.327 . . . . 1.0 110.348 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -87.58 165.39 15.49 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -148.08 128.44 13.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.58 -68.05 0.48 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 m -83.43 141.29 31.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.84 76.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.094 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -54.09 -38.59 65.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.876 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -63.31 -40.77 98.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.179 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.4 tp -63.1 -43.21 99.11 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.839 -0.345 . . . . 1.0 110.247 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.08 -48.13 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -62.65 -35.4 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.715 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -57.63 -43.21 84.65 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.34 -0.244 . . . . 1.0 110.34 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.88 -43.44 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.93 21.01 1.84 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.465 0.65 . . . . 1.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p 66.17 14.92 9.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.902 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -69.33 56.85 0.11 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.124 -0.325 . . . . 1.0 110.124 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 15.6 ptmt -114.23 122.31 46.38 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.161 -0.311 . . . . 1.0 110.161 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 142.16 93.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 O-C-N 125.188 1.555 . . . . 1.0 110.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.11 -36.79 3.41 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.02 149.01 50.92 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -112.51 151.02 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.956 0.408 . . . . 1.0 110.114 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -163.89 155.76 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.787 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -106.33 121.54 44.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.996 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 mp -111.87 129.28 56.21 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HZ2' HD12 ' A' ' 25' ' ' ILE . 27.0 tptp -92.87 123.6 36.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 56' ' ' GLU . 10.1 mm -123.52 161.28 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 55' ' ' ILE . 80.4 tt0 -130.86 134.4 46.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.075 -0.966 . . . . 1.0 109.602 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -142.34 130.12 21.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 44.06 48.08 7.41 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.022 0.439 . . . . 1.0 111.378 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 60.0 24.49 13.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.865 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 132.09 44.84 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.34 160.11 17.76 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.324 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -140.05 145.92 38.33 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.196 -0.456 . . . . 1.0 109.83 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -131.22 116.29 17.45 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.12 142.16 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 m -104.95 117.91 35.21 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.93 164.22 27.41 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.4 m -98.83 128.37 45.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -57.0 167.0 0.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.022 -0.271 . . . . 1.0 110.463 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -141.65 168.77 18.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.356 0.598 . . . . 1.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -131.29 144.12 51.04 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.113 -0.948 . . . . 1.0 109.812 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.512 ' CD1' ' ND2' ' A' ' 11' ' ' ASN . 68.6 m-85 -41.91 143.67 0.94 Allowed Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.06 -62.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.014 1.809 . . . . 1.0 114.274 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -78.98 14.6 1.33 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.402 0.281 . . . . 1.0 111.739 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -145.46 63.81 10.02 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.85 -20.62 29.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.823 1.682 . . . . 1.0 111.645 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -71.59 -34.96 70.35 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.484 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -109.93 145.32 37.09 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.02 35.42 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.042 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.31 -170.0 13.01 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -77.03 130.58 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.22 -174.13 13.6 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.26 149.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.443 ' H ' ' H ' ' A' ' 84' ' ' LEU . 96.3 p -169.06 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.45 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.443 ' H ' ' H ' ' A' ' 83' ' ' SER . 37.2 tp -72.45 83.99 1.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 84.51 0.79 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.901 -0.407 . . . . 1.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -155.19 148.63 25.09 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.961 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -67.63 142.89 56.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -63.22 140.47 58.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.22 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.35 150.44 48.28 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -167.79 -45.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.159 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.122 -0.942 . . . . 1.0 110.929 -179.796 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.403 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 3.6 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . -63.67 -51.27 55.39 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -74.01 -9.67 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 120.59 0.234 . . . . 1.0 110.383 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -147.03 103.81 3.64 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.37 134.43 45.45 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 110.003 -0.369 . . . . 1.0 110.003 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.3 p -96.77 -39.25 9.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.757 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.8 p -171.24 152.16 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.025 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.4 m -144.98 155.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.119 0.485 . . . . 1.0 110.314 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.21 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.036 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.596 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 25.5 tt0 -60.86 -158.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.596 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 12.2 m120 62.44 35.15 14.98 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.024 0.53 . . . . 1.0 111.718 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -124.91 168.54 13.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 -178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.719 ' O ' ' N ' ' A' ' 15' ' ' LYS . 9.5 Cg_endo -48.49 -7.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.484 2.123 . . . . 1.0 113.33 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' MET . . . 13.94 -57.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' A' ' 13' ' ' PRO . 88.0 tttt -62.53 107.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.912 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.79 -27.57 18.38 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.415 -0.674 . . . . 1.0 111.415 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 1.8 ttmp? -131.21 108.34 9.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -124.72 152.05 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -143.71 109.38 5.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p -173.35 83.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.848 0.832 . . . . 1.0 109.538 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 82.25 -24.95 4.5 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.181 -1.168 . . . . 1.0 110.181 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -57.69 137.08 56.84 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -84.34 135.12 34.43 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 120.51 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 mm -68.75 -45.47 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.715 0.293 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.4 p -168.96 164.52 11.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.851 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.35 131.28 53.03 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.09 35.06 23.91 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.451 0.167 . . . . 1.0 111.451 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.06 -0.26 12.12 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.26 -0.736 . . . . 1.0 111.26 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.71 132.58 46.03 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.832 0.348 . . . . 1.0 110.37 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -89.06 164.91 14.85 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.85 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' OH ' ' CE2' ' A' ' 41' ' ' TYR . 99.1 m-85 -153.96 103.97 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 p -87.83 119.75 28.48 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.047 -0.524 . . . . 1.0 109.933 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.39 84.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.475 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.58 -36.78 74.51 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.635 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -66.85 -39.37 87.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.853 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 tp -58.25 -49.08 78.35 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.771 -0.372 . . . . 1.0 110.967 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.53 -46.2 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -63.61 -40.03 95.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.553 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 57.9 t80 -61.29 -54.64 41.37 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.199 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.83 -46.71 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.315 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.1 t -56.36 -29.24 61.15 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.857 0.361 . . . . 1.0 111.948 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.6 m -77.74 -2.91 38.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.64 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -147.38 47.18 1.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.898 0.332 . . . . 1.0 111.898 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -96.69 157.15 16.04 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.415 -0.803 . . . . 1.0 108.954 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 71.41 97.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.037 0.446 . . . . 1.0 111.941 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.25 -53.75 0.62 Allowed Glycine 0 N--CA 1.471 0.969 0 CA-C-N 115.43 -0.804 . . . . 1.0 111.469 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.49 142.8 50.16 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -106.75 151.92 24.5 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.86 154.41 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -97.77 115.76 28.66 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.08 -1.082 . . . . 1.0 108.08 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -110.44 121.91 46.45 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.94 -0.393 . . . . 1.0 109.94 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -91.32 129.93 37.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 56' ' ' GLU . 33.6 mm -130.87 158.7 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 55' ' ' ILE . 12.5 pt-20 -131.97 134.31 45.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.865 -1.061 . . . . 1.0 110.24 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -143.27 131.5 21.98 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 48.12 43.47 18.44 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.861 -0.154 . . . . 1.0 111.4 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.07 1.31 3.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.605 0.362 . . . . 1.0 111.568 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.62 162.35 13.34 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.89 140.84 50.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -131.35 147.63 52.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -130.92 135.39 47.63 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.91 149.34 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 65' ' ' THR . 8.8 t -99.14 117.44 33.64 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 mt -136.4 163.17 31.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -100.8 139.24 36.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.592 -0.731 . . . . 1.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.84 166.76 8.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.0 109.904 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -136.84 174.51 10.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -132.11 148.02 52.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.552 0.741 . . . . 1.0 109.287 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -40.27 105.58 0.38 Allowed Pre-proline 0 CA--C 1.567 1.627 0 O-C-N 123.592 0.557 . . . . 1.0 110.504 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.52 -13.43 5.55 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.755 1.637 . . . . 1.0 113.081 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -103.66 14.43 31.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.431 0.292 . . . . 1.0 110.42 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -164.93 67.77 1.3 Allowed Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.436 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.32 -17.11 53.58 Favored 'Trans proline' 0 N--CA 1.505 2.178 0 C-N-CA 121.652 1.568 . . . . 1.0 111.81 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.81 -11.8 60.98 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.209 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -137.83 161.48 36.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.22 132.41 35.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.118 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.44 -3.72 5.77 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.4 132.15 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 83' ' ' SER . . . -179.21 68.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.93 19.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.581 0.229 . . . . 1.0 110.547 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 81' ' ' GLY . 96.9 p -72.35 52.72 0.28 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.136 0.493 . . . . 1.0 110.368 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 mt -69.34 152.57 44.81 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.757 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 55.29 60.17 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 1.0 110.725 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' NE2' ' CE1' ' A' ' 87' ' ' HIS . 22.2 p80 -68.19 -17.66 64.39 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.473 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' NE2' ' A' ' 86' ' ' HIS . 71.4 m80 -63.09 125.46 24.09 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.406 ' O ' ' ND1' ' A' ' 90' ' ' HIS . 59.5 t-80 -169.0 -21.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.418 ' O ' ' N ' ' A' ' 91' ' ' HIS . 70.5 m80 -70.96 -18.07 62.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.396 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 88' ' ' HIS . 74.1 m80 53.43 -87.66 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 89' ' ' HIS . 71.5 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.46 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.51 -133.18 44.77 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.51 -24.02 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 110.48 -0.193 . . . . 1.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -107.78 165.5 11.39 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.21 151.32 36.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.802 -0.636 . . . . 1.0 109.787 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.4 p -123.7 -61.53 1.38 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 108.985 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -170.79 143.52 2.11 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.342 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -136.71 143.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.536 0.334 . . . . 1.0 110.274 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.28 139.63 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.881 0.372 . . . . 1.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.98 -148.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.9 m120 70.52 28.6 3.6 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.735 0.647 . . . . 1.0 110.532 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -134.49 178.32 1.82 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 -178.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 15' ' ' LYS . 80.6 Cg_exo -51.65 -4.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.027 2.485 . . . . 1.0 112.939 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -10.77 -39.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.233 1.413 . . . . 1.0 114.192 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 13' ' ' PRO . 50.2 pttt -57.07 126.37 26.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.89 -17.44 31.63 Favored Glycine 0 CA--C 1.538 1.52 0 O-C-N 121.996 -0.44 . . . . 1.0 112.855 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -140.74 113.88 8.5 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 117.895 0.847 . . . . 1.0 108.846 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.9 142.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 108.632 -0.877 . . . . 1.0 108.632 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -137.09 103.39 5.12 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.6 t -161.47 83.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.03 -15.85 25.04 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.19 -1.164 . . . . 1.0 110.19 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' NH1' ' A' ' 57' ' ' ARG . 60.6 m-20 -69.55 139.0 53.71 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 1.0 110.271 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -94.1 155.29 17.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.438 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -107.92 118.25 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.08 -44.47 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.2 p -164.17 160.44 21.36 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -115.42 95.04 4.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 41.41 20.32 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -162.59 -126.16 0.8 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -89.22 177.74 6.53 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.75 0.31 . . . . 1.0 111.406 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -84.41 -12.46 54.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.718 -0.673 . . . . 1.0 110.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 46.56 97.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.063 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 26.1 mp0 -61.27 -40.69 95.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.8 m -85.58 121.85 28.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.951 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.54 98.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.353 . . . . 1.0 111.038 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.76 -37.75 63.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.346 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -66.29 -42.78 87.89 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 121.293 -0.163 . . . . 1.0 110.627 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.38 -46.54 89.76 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.962 -0.295 . . . . 1.0 110.318 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.95 -48.87 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -60.06 -38.68 83.53 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.858 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -57.85 -46.07 85.34 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.268 -0.27 . . . . 1.0 110.634 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.52 -43.49 98.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 109.801 -0.444 . . . . 1.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m 53.81 17.71 1.36 Allowed 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.84 -0.537 . . . . 1.0 110.753 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 46' ' ' LYS . 1.5 t 73.07 20.83 3.32 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.277 -0.874 . . . . 1.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -56.58 55.61 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.815 0.697 . . . . 1.0 111.679 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 44' ' ' SER . 67.9 mttm -110.23 150.18 29.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.827 0.451 . . . . 1.0 110.343 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 87.87 81.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.774 0.83 . . . . 1.0 110.765 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.34 -60.94 0.56 Allowed Glycine 0 N--CA 1.474 1.183 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.749 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -70.17 144.08 52.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.676 -0.308 . . . . 1.0 110.658 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.77 152.99 20.6 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.094 0.473 . . . . 1.0 109.748 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -158.68 151.02 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.592 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -102.08 125.59 48.81 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 24' ' ' ILE . 33.6 tp -110.41 125.57 53.38 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -91.06 118.59 30.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.94 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -118.77 153.72 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.56 127.96 47.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.742 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' NH1' ' OD2' ' A' ' 22' ' ' ASP . 61.3 mtp85 -138.15 124.13 20.15 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 49.4 39.17 15.78 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.136 0.494 . . . . 1.0 111.156 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.11 9.64 6.71 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.277 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -113.38 157.83 21.38 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -130.94 155.9 46.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.177 -0.465 . . . . 1.0 109.865 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.68 151.9 50.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.442 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -130.5 122.88 28.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.566 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -141.91 137.63 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 115.13 26.95 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.523 -0.917 . . . . 1.0 108.523 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 mt -136.7 163.47 30.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.125 0.57 . . . . 1.0 109.68 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -97.95 137.24 37.07 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.29 170.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -148.92 172.55 14.52 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.434 0.635 . . . . 1.0 110.204 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -132.98 143.83 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.929 -1.032 . . . . 1.0 111.156 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -59.42 144.21 84.43 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.251 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.64 -46.24 0.47 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.759 1.64 . . . . 1.0 112.591 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.15 -18.43 65.28 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 111.708 0.262 . . . . 1.0 111.708 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -132.67 75.18 73.67 Favored Pre-proline 0 N--CA 1.48 1.043 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.145 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.04 -7.81 16.4 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.265 1.977 . . . . 1.0 111.717 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.19 -10.59 41.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.284 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.615 ' NH1' ' H ' ' A' ' 83' ' ' SER . 41.5 ttm180 -144.27 151.5 39.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.736 0.303 . . . . 1.0 110.249 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -142.08 162.02 36.52 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.789 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.17 -103.14 1.18 Allowed Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.534 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 pt -65.99 143.91 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 1.0 110.606 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.37 -99.77 0.08 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.617 -0.993 . . . . 1.0 110.617 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.82 103.62 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.615 ' H ' ' NH1' ' A' ' 77' ' ' ARG . 93.1 p -68.86 157.84 35.72 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.3 mt 54.58 85.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.969 0.414 . . . . 1.0 110.501 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 28.4 mp0 -64.14 -29.49 70.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.036 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' CG ' ' N ' ' A' ' 87' ' ' HIS . 59.8 t-80 56.58 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.576 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' N ' ' CG ' ' A' ' 86' ' ' HIS . 61.1 t-80 -167.34 153.24 7.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.299 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -70.82 65.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.966 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -64.14 -44.89 90.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.316 -0.402 . . . . 1.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -168.26 -40.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.1 -0.953 . . . . 1.0 110.681 -179.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.552 ' O ' HD11 ' A' ' 24' ' ' ILE . . . 65.8 -175.39 17.62 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.79 -0.924 . . . . 1.0 110.79 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 35' ' ' ALA . 18.9 pt -66.32 -22.79 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -141.64 107.25 5.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.5 124.34 25.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.079 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 t -92.78 -18.64 22.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.98 0.419 . . . . 1.0 110.937 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.9 p -169.4 169.61 8.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.805 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.06 154.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.77 113.25 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -42.26 -36.96 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -101.9 80.41 2.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.835 0.309 . . . . 1.0 111.835 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.98 166.01 30.52 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' LYS . 51.2 Cg_exo -58.03 -31.35 92.75 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.547 1.498 . . . . 1.0 112.995 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.44 17.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.724 1.265 . . . . 1.0 110.907 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 13' ' ' PRO . 62.3 tttp -76.23 119.49 20.2 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.67 0.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.659 -0.523 . . . . 1.0 113.37 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -127.34 106.04 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.823 0.849 . . . . 1.0 108.719 -178.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -119.81 141.1 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.341 -0.985 . . . . 1.0 108.341 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -143.96 104.39 4.14 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.0 t -163.18 84.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -11.61 58.11 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.1 176.77 5.51 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -123.01 143.14 50.13 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.259 0.552 . . . . 1.0 110.283 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -107.22 117.5 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.056 -0.975 . . . . 1.0 108.804 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.05 -43.98 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.435 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -168.54 167.29 11.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.753 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.38 135.18 47.76 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.65 27.24 1.44 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 111.984 0.364 . . . . 1.0 111.984 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.17 -11.71 56.87 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.281 -0.728 . . . . 1.0 111.281 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.53 131.64 34.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.56 152.44 20.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.682 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.18 127.14 16.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -78.6 -74.82 0.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.828 0.347 . . . . 1.0 110.289 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.0 t -82.59 143.13 31.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.812 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 3' ' ' ILE . . . -53.52 -34.49 58.32 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.993 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.64 -41.71 70.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 1.0 110.842 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -65.71 -46.63 78.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.385 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.52 -42.31 91.98 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.234 -0.291 . . . . 1.0 110.572 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.31 -44.81 99.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.26 -37.41 80.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.531 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.35 -50.68 73.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.959 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mm -59.93 -49.92 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.039 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.41 ' OG ' ' NZ ' ' A' ' 45' ' ' LYS . 56.8 p 51.96 28.53 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.409 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 77.64 91.31 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.196 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' NZ ' ' OG ' ' A' ' 43' ' ' SER . 59.6 mttp -149.61 38.19 0.76 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.26 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -78.47 155.2 29.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 56.57 124.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.712 0.768 . . . . 1.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.73 -64.35 0.3 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.98 154.2 40.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -122.63 153.3 39.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' CG1' HD21 ' A' ' 68' ' ' LEU . 2.8 p -159.1 156.33 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 m -99.02 113.44 25.63 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.59 -1.263 . . . . 1.0 107.59 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -101.5 126.72 48.34 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -103.09 131.88 49.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 56' ' ' GLU . 63.8 mt -135.86 163.58 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 55' ' ' ILE . 79.6 tt0 -122.05 130.36 53.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.2 -0.909 . . . . 1.0 109.248 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 60' ' ' LYS . 80.7 mtp180 -138.46 121.92 17.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 39.85 44.85 1.43 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 67.87 32.97 4.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.427 0.454 . . . . 1.0 110.942 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 57' ' ' ARG . 48.2 mtmt -141.3 142.0 33.88 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.117 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -119.5 152.18 37.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.753 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.54 141.74 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -130.67 122.4 27.29 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.87 149.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 114.71 26.39 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.86 166.45 24.42 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.46 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.2 m -94.32 128.59 40.91 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD21 ' CG1' ' A' ' 51' ' ' VAL . 75.2 mt -26.91 -60.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -154.17 167.33 30.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.821 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.26 145.24 48.93 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -38.97 160.04 0.09 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 123.332 0.395 . . . . 1.0 111.689 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -44.84 -50.24 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.046 1.831 . . . . 1.0 114.26 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -122.16 -43.02 2.34 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.656 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -62.85 110.46 3.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.443 0.464 . . . . 1.0 110.847 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -87.3 -49.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.129 1.886 . . . . 1.0 111.672 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 22.1 p-10 -60.71 -6.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.68 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -125.03 130.51 52.45 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.266 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.85 37.7 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.08 143.82 0.05 OUTLIER Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.249 -0.741 . . . . 1.0 111.249 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.01 -46.9 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.39 -170.02 34.45 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 110.354 -1.098 . . . . 1.0 110.354 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.62 148.24 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t 49.45 17.88 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.661 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.39 101.95 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.93 -52.13 46.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -168.35 152.72 6.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.555 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.98 128.21 35.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -74.12 120.13 19.27 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.158 -0.312 . . . . 1.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.479 ' CD2' ' H ' ' A' ' 89' ' ' HIS . 10.6 p80 -70.36 122.47 19.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.728 0.299 . . . . 1.0 110.284 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -66.01 -40.49 91.14 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.102 -0.332 . . . . 1.0 110.102 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.044 -0.979 . . . . 1.0 110.367 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.66 -123.66 31.1 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.394 -0.682 . . . . 1.0 111.394 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -97.2 9.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.15 134.64 45.65 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.87 0.367 . . . . 1.0 110.078 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -79.93 112.63 17.41 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.21 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -91.01 -26.31 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.804 0.335 . . . . 1.0 110.802 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -168.16 156.66 8.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -146.87 152.56 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -87.89 134.19 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.645 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -56.13 -170.79 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.784 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.3 t30 55.55 38.99 30.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.186 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' ALA . 2.7 mtt -119.99 173.26 3.77 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.749 ' O ' ' N ' ' A' ' 15' ' ' LYS . 89.0 Cg_exo -50.74 -3.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.575 2.183 . . . . 1.0 113.802 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' MET . . . 1.86 -49.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 125.259 1.599 . . . . 1.0 113.809 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 13' ' ' PRO . 87.4 tttt -54.16 141.93 27.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.62 -24.13 0.01 OUTLIER Glycine 0 CA--C 1.556 2.614 0 CA-C-O 119.319 -0.712 . . . . 1.0 114.428 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.2 tttt -124.6 106.81 10.41 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.2 1.5 . . . . 1.0 108.552 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.0 tt -115.34 139.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -140.98 110.33 6.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.7 p -174.5 89.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 83.25 -19.39 13.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -66.48 155.91 36.27 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -104.83 140.24 38.4 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.928 0.394 . . . . 1.0 110.438 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.64 116.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.9 -48.39 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.978 0.418 . . . . 1.0 109.972 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.2 p -164.37 161.7 21.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.849 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.97 -98.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.942 0.401 . . . . 1.0 110.691 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.6 62.99 1.71 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.371 0.668 . . . . 1.0 110.458 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.09 -2.81 6.29 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.42 113.74 27.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 110.119 -0.326 . . . . 1.0 110.119 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -87.12 93.64 9.42 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.69 133.74 40.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.284 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.92 -52.12 3.99 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 p -83.28 135.42 34.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.32 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.66 91.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.02 -39.95 63.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.957 0.408 . . . . 1.0 111.088 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -71.74 -44.52 63.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.796 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.07 -49.9 75.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 121.085 -0.246 . . . . 1.0 111.069 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 40' ' ' ASP . 19.1 tt -63.83 -44.9 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 120.487 -0.485 . . . . 1.0 110.04 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 39' ' ' ILE . 98.0 m-20 -62.69 -37.94 88.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.34 -46.96 82.76 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.5 -42.79 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m 54.6 25.18 6.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.304 0.573 . . . . 1.0 110.425 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' LYS . 9.9 m 61.06 10.75 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.152 -0.931 . . . . 1.0 111.372 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.6 64.19 0.02 OUTLIER 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.549 0.531 . . . . 1.0 110.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' SER . 97.5 mttt -97.91 173.99 6.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.684 -0.487 . . . . 1.0 109.684 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 59.99 103.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 1.0 111.521 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.88 -56.76 0.6 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 111.422 -0.671 . . . . 1.0 111.422 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -72.72 127.39 32.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -94.89 148.31 22.44 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.8 t -150.66 157.31 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -98.82 125.24 44.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.17 110.15 12.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' HZ1' ' NH2' ' A' ' 63' ' ' ARG . 68.3 mttm -89.23 143.96 26.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.1 mm -119.48 151.8 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -113.7 126.58 55.4 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.148 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -142.38 122.59 13.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 49.92 45.99 24.62 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.138 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 62.4 32.98 16.6 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.865 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 173.43 7.8 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.799 0.44 . . . . 1.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.3 pm0 -138.82 141.97 38.69 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -119.52 149.71 41.46 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' NH2' ' HZ1' ' A' ' 54' ' ' LYS . 58.0 ttm-85 -127.15 118.23 23.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.687 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.11 139.88 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 p -98.77 117.32 32.98 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.2 mt -134.49 157.34 46.74 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -97.14 142.32 29.2 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.11 166.83 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 1.0 110.386 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -141.52 159.12 42.88 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.403 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.97 143.82 44.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -43.08 146.18 0.84 Allowed Pre-proline 0 CA--C 1.557 1.229 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.863 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -68.31 -74.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 121.817 1.678 . . . . 1.0 113.12 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 22.1 p-10 -71.39 13.74 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -144.9 65.28 12.08 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.15 -11.28 16.3 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.387 2.058 . . . . 1.0 111.394 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -82.78 -8.25 59.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -137.87 152.27 48.88 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.14 151.56 47.88 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.982 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.11 175.91 1.2 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.23 -0.748 . . . . 1.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -82.45 124.79 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.86 151.37 0.02 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.25 -72.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.2 t -167.8 138.87 2.9 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.373 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 mt -63.41 -42.79 98.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.501 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.12 112.24 21.73 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.994 -0.373 . . . . 1.0 109.994 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -72.7 66.17 0.73 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.064 0.459 . . . . 1.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -154.62 89.87 1.28 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.047 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.75 5.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.127 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.4 m80 53.58 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.787 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -65.67 138.05 57.73 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 C--O 1.222 -0.376 0 CA-C-O 117.983 -1.008 . . . . 1.0 111.161 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 4' ' ' TYR . . . 64.42 -170.24 22.38 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 pt -63.3 -1.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 110.628 -0.138 . . . . 1.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' GLY . 75.0 m-85 -109.81 -172.27 2.01 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.27 117.63 6.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.183 -0.462 . . . . 1.0 109.759 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -101.13 -41.92 6.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.894 0.378 . . . . 1.0 110.626 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.3 m -166.54 168.91 14.25 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.406 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.17 143.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.198 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.27 131.53 34.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 N-CA-C 109.225 -0.657 . . . . 1.0 109.225 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -57.49 178.27 0.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 1.0 110.892 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.09 34.46 23.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.669 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.451 ' C ' ' H ' ' A' ' 14' ' ' ALA . 5.9 mtt -123.44 172.76 5.15 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.09 -0.337 . . . . 1.0 110.09 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' O ' ' N ' ' A' ' 15' ' ' LYS . 81.2 Cg_exo -50.1 -6.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.625 2.217 . . . . 1.0 113.332 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -4.41 -47.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 125.334 1.646 . . . . 1.0 112.895 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 13' ' ' PRO . 64.3 tttm -49.36 133.64 19.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.25 -0.886 . . . . 1.0 108.832 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.9 -9.71 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.468 -0.787 . . . . 1.0 113.128 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 15' ' ' LYS . 86.2 tttt -126.43 105.91 9.1 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.758 1.279 . . . . 1.0 108.748 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -121.9 145.6 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.78 103.0 4.0 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.2 t -155.69 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.281 -1.378 . . . . 1.0 107.281 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -15.66 44.12 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.94 160.27 32.19 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -117.36 148.87 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.19 122.54 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -71.59 -51.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.464 . . . . 1.0 110.583 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -166.63 167.18 15.58 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.38 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.11 139.89 48.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.1 t70 56.92 34.16 24.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.654 -0.248 . . . . 1.0 111.088 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.89 4.08 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -108.2 127.03 53.47 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -79.5 172.49 13.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.624 -0.509 . . . . 1.0 109.624 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -149.19 113.16 5.15 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -65.85 -49.92 66.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.357 -0.383 . . . . 1.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.7 t -91.65 128.43 37.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.15 0.5 . . . . 1.0 110.139 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.81 83.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -60.36 -35.99 76.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.984 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.23 -34.49 78.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.345 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.25 -46.71 87.76 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.52 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 39' ' ' ILE . 1.7 mp -62.97 -45.77 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.176 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.55 -55.17 29.87 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.431 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.1 mt -66.92 -46.93 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.653 -0.249 . . . . 1.0 111.067 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.2 p -57.83 -22.46 47.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.897 0.38 . . . . 1.0 111.548 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.0 m -85.4 -5.59 59.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.276 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -150.16 42.7 0.85 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 119.57 -0.252 . . . . 1.0 111.006 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 75.1 tttt -109.64 124.83 51.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 165.74 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.65 -19.86 8.04 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -60.88 143.15 55.46 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -97.31 156.18 16.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.235 0.541 . . . . 1.0 109.595 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 52' ' ' THR . 7.6 p -161.28 158.55 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.411 -0.813 . . . . 1.0 109.666 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 51' ' ' VAL . 24.3 m -101.07 126.37 47.76 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.47 129.51 48.82 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -104.69 132.75 50.56 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.35 157.49 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -115.5 126.76 54.7 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -140.07 118.26 11.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 44.34 43.8 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.782 0.325 . . . . 1.0 111.303 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 66.03 31.19 9.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.755 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -135.08 136.48 42.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.228 -0.656 . . . . 1.0 109.228 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.96 146.78 27.81 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -121.07 153.81 36.93 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.196 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -132.02 124.17 28.76 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.546 0.529 . . . . 1.0 109.7 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.12 148.36 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.9 m -107.01 118.16 35.97 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.71 164.54 28.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.081 0.552 . . . . 1.0 109.71 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -98.38 148.2 23.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' ALA . 96.4 mt -73.16 -179.0 3.1 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.763 0.316 . . . . 1.0 110.289 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -154.22 145.23 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.319 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.26 146.33 26.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.201 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -40.44 105.33 0.37 Allowed Pre-proline 0 CA--C 1.561 1.373 0 O-C-N 123.631 0.582 . . . . 1.0 110.513 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 -10.04 3.38 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.628 1.552 . . . . 1.0 112.768 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -114.63 2.39 14.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.755 0.422 . . . . 1.0 111.159 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.96 67.45 5.25 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.328 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -17.4 53.92 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.916 1.744 . . . . 1.0 111.852 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -68.79 -17.85 64.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.338 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -137.49 158.89 43.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.62 135.93 47.34 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.202 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.98 -156.09 41.42 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.8 mt 57.06 75.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.808 0.337 . . . . 1.0 110.146 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.9 87.22 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 84' ' ' LEU . 9.4 p -59.05 -30.87 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.774 0.321 . . . . 1.0 110.343 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 85' ' ' GLU . 75.8 m 52.91 -90.96 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' O ' ' ND1' ' A' ' 86' ' ' HIS . 62.8 tp 54.66 -82.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.588 0.555 . . . . 1.0 110.287 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 83' ' ' SER . 94.6 mt-10 -60.37 137.5 58.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.96 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 84' ' ' LEU . 21.7 p-80 -166.92 -177.03 3.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 54.86 14.71 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.875 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -61.28 -47.85 84.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.486 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.27 134.03 48.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.081 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -62.61 -47.84 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.473 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.261 179.783 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.28 -135.57 3.09 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.581 -1.007 . . . . 1.0 110.581 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.0 pt -60.94 -7.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 O-C-N 122.844 -0.21 . . . . 1.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -145.75 121.86 10.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 1.0 110.695 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.05 100.2 5.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.032 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -92.0 -21.09 20.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 97.8 p -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -144.21 143.42 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.74 133.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.14 169.8 0.16 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.847 -0.16 . . . . 1.0 111.069 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 11' ' ' ASN . 1.2 m-80 57.63 35.03 25.26 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.415 0.447 . . . . 1.0 111.401 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.0 mmm -120.53 160.45 43.99 Favored Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 122.971 0.508 . . . . 1.0 109.702 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 15' ' ' LYS . 38.3 Cg_endo -62.17 -7.22 9.55 Favored 'Trans proline' 0 N--CA 1.483 0.887 0 C-N-CA 122.327 2.018 . . . . 1.0 112.065 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -27.49 -17.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.886 1.439 . . . . 1.0 114.886 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 13' ' ' PRO . 9.9 ttmm -56.92 117.08 3.61 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -23.2 1.12 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 15' ' ' LYS . 14.5 mttt -74.28 -163.2 0.18 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.49 151.98 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 115.153 -0.93 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -132.89 173.17 11.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.864 -1.516 . . . . 1.0 109.431 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' VAL . 2.6 m -60.01 117.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.905 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.26 71.34 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.025 -0.989 . . . . 1.0 112.23 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.7 168.84 19.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.709 1.254 . . . . 1.0 109.688 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -140.78 164.46 30.15 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.403 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -108.52 117.06 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.9 mm -68.04 -43.5 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -161.73 167.91 24.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.553 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -126.53 108.1 10.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.486 -0.779 . . . . 1.0 109.86 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t0 42.63 21.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.952 0.406 . . . . 1.0 112.025 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . -165.71 -114.26 0.3 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.97 177.13 7.89 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.225 0.536 . . . . 1.0 110.437 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.5 p30 -67.6 163.03 22.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.888 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -139.2 133.45 31.41 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.837 0.351 . . . . 1.0 110.215 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -66.36 -40.38 89.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.001 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.9 m -96.58 115.47 27.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.567 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.28 -24.03 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.759 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -57.04 -35.03 68.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.053 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -64.26 -43.99 93.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.286 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -63.07 -50.32 71.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.432 0.634 . . . . 1.0 110.101 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.59 -50.76 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.754 -0.657 . . . . 1.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.4 -39.49 83.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.619 0.247 . . . . 1.0 110.51 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.97 -44.91 94.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.77 -42.87 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t 56.1 25.39 8.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.269 0.557 . . . . 1.0 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 46' ' ' LYS . 14.1 m 61.08 12.94 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.237 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.26 62.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.755 0.659 . . . . 1.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 67.6 mttm -104.14 158.1 16.66 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' LYS . . . 83.23 96.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.036 0.446 . . . . 1.0 110.334 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.92 -51.94 0.88 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.026 -0.83 . . . . 1.0 111.026 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.41 148.39 45.25 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.579 -0.365 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.56 159.27 22.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.82 150.43 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.864 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -106.06 123.41 47.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -118.72 127.16 53.3 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.774 0.43 . . . . 1.0 109.882 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -90.42 131.79 35.99 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.273 -0.639 . . . . 1.0 109.273 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 56' ' ' GLU . 77.7 mt -131.43 165.29 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.806 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 55' ' ' ILE . 78.8 tt0 -127.76 133.23 49.48 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.855 -1.066 . . . . 1.0 109.76 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -139.61 125.52 19.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 44.37 43.57 6.19 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.268 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 63.42 31.2 15.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.199 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.26 119.24 12.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -85.71 146.02 27.01 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 110.035 -0.358 . . . . 1.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -134.32 154.77 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.035 -0.529 . . . . 1.0 109.578 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.986 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.16 132.33 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.6 m -98.71 115.58 29.03 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.36 164.01 28.72 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -97.06 137.68 35.75 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.795 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.456 HD23 ' NZ ' ' A' ' 17' ' ' LYS . 87.4 mt -61.38 171.72 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.377 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -149.27 164.0 36.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.04 0.448 . . . . 1.0 110.39 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.16 143.06 50.25 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.641 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -38.24 134.95 0.89 Allowed Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 123.592 0.558 . . . . 1.0 111.349 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.91 -12.98 24.09 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.731 1.621 . . . . 1.0 113.034 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.78 11.23 24.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.409 0.284 . . . . 1.0 110.917 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -162.35 67.11 1.94 Allowed Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 116.55 -0.296 . . . . 1.0 110.497 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.17 -9.02 22.9 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.883 1.722 . . . . 1.0 111.533 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.86 -9.46 59.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.323 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -147.15 156.83 43.31 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.621 -0.511 . . . . 1.0 109.621 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -141.2 166.23 25.36 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.633 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.13 -118.41 12.05 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 pt -64.88 158.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 122.464 -0.433 . . . . 1.0 110.257 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.44 125.88 1.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.62 144.09 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.779 0.323 . . . . 1.0 110.341 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -62.08 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.528 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 mt 55.12 105.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.807 0.337 . . . . 1.0 110.71 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.813 0.34 . . . . 1.0 110.493 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -168.11 131.12 1.54 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.941 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -169.19 129.73 1.1 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -169.73 126.49 0.87 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -168.74 -31.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.45 129.85 41.21 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.009 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.917 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 7.2 p30 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.539 ' O ' HD11 ' A' ' 24' ' ' ILE . . . -71.36 -67.39 1.88 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 1.0 111.327 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.56 -13.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 110.721 -0.103 . . . . 1.0 110.721 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -145.78 113.56 6.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.107 -0.331 . . . . 1.0 110.107 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.29 108.4 6.14 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.2 t -84.72 -34.54 22.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.978 0.418 . . . . 1.0 110.707 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -164.64 160.11 19.7 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.002 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -147.83 151.45 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.17 138.32 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.736 -0.665 . . . . 1.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.21 -174.81 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 116.348 -0.387 . . . . 1.0 109.986 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.79 34.37 21.71 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.462 0.172 . . . . 1.0 111.335 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' ALA . 13.2 mmt -115.29 160.54 33.84 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 123.583 0.753 . . . . 1.0 109.17 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.733 ' O ' ' N ' ' A' ' 15' ' ' LYS . 20.1 Cg_endo -57.62 -1.07 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.08 2.52 . . . . 1.0 113.234 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 12' ' ' MET . . . -16.93 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.469 1.285 . . . . 1.0 114.469 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 13' ' ' PRO . 37.1 ttpt -52.31 150.74 4.44 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.1 -16.78 0.01 OUTLIER Glycine 0 CA--C 1.551 2.329 0 C-N-CA 120.618 -0.801 . . . . 1.0 114.019 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 15' ' ' LYS . 19.2 ptmt -136.29 104.72 5.72 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.168 1.484 . . . . 1.0 109.14 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.27 131.31 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.82 -1.175 . . . . 1.0 109.231 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -108.55 -168.13 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t 78.08 89.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 124.051 0.845 . . . . 1.0 110.492 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.05 -21.46 11.84 Favored Glycine 0 N--CA 1.467 0.711 0 CA-C-N 114.485 -1.234 . . . . 1.0 111.285 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -65.61 144.88 56.68 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -105.36 144.45 32.12 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.539 HD11 ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -106.73 121.37 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.401 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.81 -47.46 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.189 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.8 p -166.24 162.4 17.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.843 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -93.92 -91.8 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.035 0.445 . . . . 1.0 110.921 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.3 t70 -94.71 59.83 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.819 0.848 . . . . 1.0 110.248 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.73 -2.91 0.75 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 121.424 -0.417 . . . . 1.0 112.204 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 28' ' ' ASP . 4.0 tmtm? -101.79 117.74 35.48 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -68.94 164.4 22.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -150.03 95.35 2.28 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 110.015 -0.365 . . . . 1.0 110.015 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -65.11 -45.41 85.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.581 -0.525 . . . . 1.0 109.581 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.4 m -86.91 124.67 33.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.042 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.51 83.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.884 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -60.35 -37.3 80.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.94 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -64.11 -37.8 88.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.07 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.25 -44.29 95.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -62.68 -46.41 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.27 -38.68 87.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.6 -48.41 79.48 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.241 -0.287 . . . . 1.0 110.434 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.22 -41.52 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.8 m 60.39 27.28 16.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.017 0.437 . . . . 1.0 111.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 62.64 7.83 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.195 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -69.46 63.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.313 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 97.3 mttt -109.63 125.02 52.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.76 -0.638 . . . . 1.0 109.672 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' LYS . . . 131.12 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.547 1.539 . . . . 1.0 111.218 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.31 -49.18 2.67 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.317 -0.401 . . . . 1.0 112.16 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.92 179.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.4 149.9 45.99 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 68' ' ' LEU . 9.8 p -154.96 155.11 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ALA . 85.3 m -97.31 135.62 38.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.834 -1.173 . . . . 1.0 107.834 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.55 111.42 12.24 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.98 134.15 35.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 56' ' ' GLU . 11.1 mm -122.88 158.18 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . 39.2 tp10 -116.75 129.12 55.92 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.431 -0.804 . . . . 1.0 109.785 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -139.71 116.09 10.59 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.867 -0.42 . . . . 1.0 109.867 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 45.59 49.64 10.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.131 0.491 . . . . 1.0 111.238 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 62.77 31.84 16.32 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.96 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -132.32 151.3 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 35.4 mp0 -119.74 142.99 48.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.142 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -127.72 151.86 48.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -128.42 119.55 25.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 t -139.35 135.0 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.1 m -93.17 117.04 29.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.879 -0.785 . . . . 1.0 108.879 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -133.39 156.73 47.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -90.46 146.25 24.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.1 mp -63.62 162.71 12.54 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -145.38 154.25 42.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.325 0.583 . . . . 1.0 110.352 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.36 144.88 51.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.665 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -40.67 142.17 0.83 Allowed Pre-proline 0 CA--C 1.557 1.241 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.248 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HG2' ' H ' ' A' ' 73' ' ' ASP . 86.5 Cg_endo -71.17 -72.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 121.779 1.652 . . . . 1.0 114.301 -178.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 72' ' ' PRO . 25.9 p-10 -71.87 10.05 0.78 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 111.951 0.352 . . . . 1.0 111.951 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.35 67.01 25.09 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 109.968 -0.382 . . . . 1.0 109.968 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.9 -8.65 16.78 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.231 1.954 . . . . 1.0 111.371 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.49 -23.07 66.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.085 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.523 HH12 ' CB ' ' A' ' 83' ' ' SER . 59.7 ttp180 -145.35 157.04 44.12 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.9 152.58 47.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.35 140.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.36 146.59 13.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -158.76 175.7 35.75 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 110.053 -1.219 . . . . 1.0 110.053 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.62 -32.94 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 1.0 110.401 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' HH12 ' A' ' 77' ' ' ARG . 39.7 t 54.12 -174.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.568 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.3 mt -69.55 142.42 53.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -34.64 78.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.277 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -158.29 179.72 8.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.102 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -155.28 159.64 40.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -68.92 135.23 50.69 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.47 140.35 58.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.82 -41.98 98.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.148 -0.929 . . . . 1.0 110.423 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 2' ' ' GLY . 64.7 t30 . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 1' ' ' ASN . . . 62.15 -144.25 49.03 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.88 -51.22 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -68.08 144.03 55.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.823 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.79 168.24 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.395 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -158.63 -3.67 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.071 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -167.66 147.23 5.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -153.51 161.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.835 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.55 143.43 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.179 0.592 . . . . 1.0 109.49 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.14 -154.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.222 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 60.06 35.01 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.307 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.9 mtt -132.82 156.92 79.56 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 15' ' ' LYS . 74.8 Cg_exo -55.06 -30.59 70.96 Favored 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 121.599 1.533 . . . . 1.0 112.772 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 43.74 18.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.9 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 17' ' ' LYS . 62.6 tttp -65.35 124.95 23.6 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.59 29.24 0.01 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 123.362 0.506 . . . . 1.0 113.451 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.1 ptpt -139.5 106.4 5.41 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.91 146.9 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -148.25 108.67 4.13 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 20' ' ' VAL . 13.5 p 178.36 88.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.53 -27.07 5.4 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.397 -1.081 . . . . 1.0 110.397 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.26 124.61 26.0 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -76.53 149.82 36.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.066 -0.515 . . . . 1.0 109.802 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -104.14 127.86 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.1 mt -64.17 -53.24 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.006 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 t -172.94 166.12 5.1 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.662 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 135.72 44.29 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' H ' HG23 ' A' ' 52' ' ' THR . 1.3 m-20 55.25 47.77 20.81 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.07 0.462 . . . . 1.0 110.835 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.86 21.14 0.53 Allowed Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.675 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 59.9 tttp -115.61 127.49 55.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.098 0.559 . . . . 1.0 110.209 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.58 168.99 18.24 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' CE2' ' O ' ' A' ' 30' ' ' LYS . 88.7 m-85 -145.2 112.71 6.22 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.83 -0.434 . . . . 1.0 109.83 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -68.48 -39.37 81.36 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.1 m -136.59 146.96 46.68 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.207 0.527 . . . . 1.0 110.836 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.33 -28.09 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.075 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.06 -47.05 78.67 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.713 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -65.05 -47.01 78.85 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.576 -0.527 . . . . 1.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -52.65 -48.62 66.32 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.426 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.86 -43.91 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.72 -44.21 93.85 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.055 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -60.09 -51.92 67.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 121.071 -0.251 . . . . 1.0 111.004 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -61.81 -43.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 m 50.88 30.0 4.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.272 0.558 . . . . 1.0 110.634 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 1.9 m 66.81 11.23 8.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.71 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.81 59.59 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.938 0.399 . . . . 1.0 110.524 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 68' ' ' LEU . 68.7 mttm -98.72 178.41 4.99 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.771 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.63 118.7 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.274 0.359 . . . . 1.0 110.942 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.74 -73.0 1.03 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 68' ' ' LEU . 37.8 t70 -65.9 147.76 52.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.672 0.272 . . . . 1.0 110.345 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.46 177.18 5.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.74 156.0 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.296 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 52' ' ' THR . 9.6 t -114.01 107.97 16.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.03 126.63 48.93 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -105.46 151.24 24.49 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.257 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mm -124.47 151.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -118.25 132.77 56.29 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.492 -0.777 . . . . 1.0 109.809 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -137.69 99.54 3.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.778 -0.823 . . . . 1.0 108.778 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 51.55 57.37 6.64 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.293 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.51 34.99 4.37 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.526 0.195 . . . . 1.0 111.526 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -132.09 104.06 6.6 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.058 -0.401 . . . . 1.0 110.003 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -83.77 149.51 26.39 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.6 143.06 41.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -110.62 128.37 55.65 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.03 151.1 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.581 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.3 t -126.46 120.25 29.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -134.84 151.35 50.85 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 120.983 0.42 . . . . 1.0 110.044 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.9 m -79.21 139.49 37.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.38 -0.827 . . . . 1.0 109.019 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 46' ' ' LYS . 85.0 mt -64.83 146.2 55.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.628 -0.715 . . . . 1.0 109.712 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -125.72 169.64 12.36 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -129.81 147.72 51.61 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.473 0.709 . . . . 1.0 109.312 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -53.35 148.22 17.16 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.718 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.92 -74.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.529 1.486 . . . . 1.0 113.674 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.2 6.33 1.34 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -140.79 67.25 28.45 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.79 -8.88 16.99 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.433 2.088 . . . . 1.0 111.665 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.17 0.64 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.409 0.284 . . . . 1.0 110.646 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -137.69 146.86 44.3 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 44' ' ' SER . . . -142.16 142.64 32.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.38 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.06 -172.11 37.25 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.646 -0.982 . . . . 1.0 110.646 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.9 -36.31 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.44 128.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.901 -1.28 . . . . 1.0 109.901 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -165.79 148.88 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 m -160.36 127.99 4.52 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 84' ' ' LEU . 4.0 mm? -76.56 137.95 39.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.87 151.58 46.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -163.43 18.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 83.6 t60 53.27 93.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.578 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -63.17 140.29 58.86 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.04 -42.22 93.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.855 0.359 . . . . 1.0 110.385 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -163.87 154.33 15.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.257 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.062 179.658 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 24' ' ' ILE . . . -62.17 -42.67 99.73 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.65 -23.17 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.584 0.231 . . . . 1.0 110.493 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -148.79 106.44 3.67 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.83 112.02 8.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.915 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -85.77 -23.85 27.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.776 0.322 . . . . 1.0 110.513 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.6 p -167.12 152.01 7.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.614 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.05 155.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.628 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.73 134.69 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.505 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -66.51 -137.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 61.91 19.59 10.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.389 0.431 . . . . 1.0 110.435 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.571 ' CE ' ' HZ3' ' A' ' 17' ' ' LYS . 2.3 ptp -115.42 162.78 22.98 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 122.917 0.487 . . . . 1.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' LYS . 18.5 Cg_endo -56.49 -13.8 11.31 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.387 2.058 . . . . 1.0 112.067 179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 38.8 23.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.747 0.654 . . . . 1.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 17' ' ' LYS . 17.9 tptm -60.22 106.6 0.54 Allowed 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.51 29.39 0.01 OUTLIER Glycine 0 CA--C 1.54 1.606 0 O-C-N 123.395 0.435 . . . . 1.0 112.256 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HZ3' ' CE ' ' A' ' 12' ' ' MET . 1.0 OUTLIER -128.34 104.46 7.73 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -178.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.26 140.52 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 55.7 mp0 -141.53 108.75 5.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 20' ' ' VAL . 12.4 p -177.71 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.59 -21.61 10.56 Favored Glycine 0 N--CA 1.469 0.863 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.39 161.44 22.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -108.53 140.02 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.095 0.474 . . . . 1.0 109.775 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -98.56 115.35 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 -179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.19 -48.51 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.138 0.494 . . . . 1.0 110.202 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -167.71 165.57 14.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.25 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.26 40.73 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 t70 55.71 32.06 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.375 0.131 . . . . 1.0 111.328 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.58 -2.46 11.19 Favored Glycine 0 N--CA 1.464 0.503 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -94.97 131.12 41.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.837 0.351 . . . . 1.0 110.343 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -88.03 160.58 17.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.515 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -153.08 95.66 1.98 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.929 -0.397 . . . . 1.0 109.929 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.1 -41.7 90.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -93.54 127.24 39.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.419 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.24 72.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.211 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -56.0 -39.1 71.36 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.31 0.576 . . . . 1.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.54 -44.67 74.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.8 tp -57.89 -53.62 56.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.167 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' ASP . 16.5 tt -62.16 -43.64 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 -178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' ILE . 37.9 t70 -61.16 -38.89 88.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.23 -45.62 87.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 110.21 -0.292 . . . . 1.0 110.21 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.81 -42.74 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 178.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 t 53.08 28.13 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.335 0.588 . . . . 1.0 110.822 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 t 63.78 16.52 9.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.188 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -67.77 56.99 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.459 0.475 . . . . 1.0 111.148 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 9.5 ptpt -124.4 133.93 53.26 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 46' ' ' LYS . . . 158.27 -5.32 0.0 OUTLIER 'General case' 0 C--N 1.341 0.205 0 O-C-N 124.605 1.191 . . . . 1.0 110.66 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.39 -30.96 0.1 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.024 -1.23 . . . . 1.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.19 146.55 50.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.71 149.79 21.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.066 0.46 . . . . 1.0 110.184 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.85 150.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.669 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 p -100.98 112.16 24.54 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.4 tp -116.51 120.14 37.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -91.6 136.71 32.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 56' ' ' GLU . 49.8 mm -123.5 160.9 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 55' ' ' ILE . 47.5 tp10 -115.91 127.69 55.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -142.0 123.93 15.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 43.32 45.72 5.21 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 111.803 0.297 . . . . 1.0 111.803 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 63.41 30.29 15.45 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.301 0.376 . . . . 1.0 111.213 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -136.13 151.23 49.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -118.87 149.99 40.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.021 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -135.63 146.22 47.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.644 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -131.31 135.03 46.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.96 -0.756 . . . . 1.0 108.96 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.23 151.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.4 m -98.01 115.79 28.92 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.87 -0.789 . . . . 1.0 108.87 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 66' ' ' LEU . 1.3 pt? -137.19 167.17 22.08 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.74 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -107.13 138.53 43.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.706 -0.849 . . . . 1.0 108.706 176.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.58 170.51 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.967 0.413 . . . . 1.0 110.279 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -147.79 162.33 39.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 1.0 109.946 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -131.58 142.27 49.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.834 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -55.95 140.86 68.54 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.881 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.98 -61.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 121.85 1.7 . . . . 1.0 112.903 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -59.46 -11.05 3.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.55 0.204 . . . . 1.0 111.55 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.87 77.27 57.38 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.21 -14.63 8.26 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.682 2.255 . . . . 1.0 111.42 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.62 -25.96 62.37 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.443 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -137.25 154.34 50.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.939 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.5 146.49 42.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.73 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 55.21 91.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.496 -0.642 . . . . 1.0 111.496 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.9 tt -148.91 142.89 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.858 0.361 . . . . 1.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.74 89.72 1.5 Allowed Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.219 -1.152 . . . . 1.0 110.219 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.77 138.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.3 t -73.16 87.14 1.41 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.87 0.367 . . . . 1.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.74 -36.95 85.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.397 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -55.36 -22.43 19.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -61.12 -49.1 78.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.411 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -84.21 151.26 24.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.283 -0.417 . . . . 1.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -64.85 134.75 54.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.125 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -66.11 126.24 28.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -73.96 143.92 45.45 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.015 -0.993 . . . . 1.0 109.922 179.987 . . . . . . . . 0 0 . 1 stop_ save_